clomipramine has been researched along with Depression in 249 studies
Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To observe the efficacy of Modified Xiaoyao Decoction (MXD) combining clomipramine in treatment of depression." | 9.12 | [Study on Modified Xiaoyao Decoction combining Clomipramine treating depression]. ( Liang, SC; Sun, QZ; Yu, GH, 2007) |
| ") of yohimbine in 12 patients with depression with clomipramine-induced orthostatic hypotension." | 9.06 | Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine. ( Bensimon, G; Diquet, B; Isnard, F; Lacomblez, L; Lecrubier, Y; Puech, AJ, 1989) |
| "Forty-two patients aged between 19 and 70 years (30 women and 12 men) suffering from primary unipolar depression were randomly selected and treated under double-blind conditions with either mianserin (Lantanon; Organon) or clomipramine (Anafranil; Ciba-Geigy) after an initial wash-out period." | 9.05 | Mianserin and clomipramine in the treatment of depression. ( Levin, A, 1982) |
| "A double-blind, randomized trial is described which was designed to compare the clinical effect of 100 mg daily of maprotiline (Ludiomil) and of clomipramine (Anafranil) given by the intravenous route in forty hospitalized female patients with severe and resistant primary depression." | 9.05 | Intravenous maprotiline in severe and resistant primary depression: a double-blind comparison with clomipramine. ( Drago, F; Grossi, E; Motta, A, 1983) |
| " After oral treatment with clomipramine (50 mg/kg/day) for four weeks, most of the depression-like behaviors were reversed, whereas the motivational reduction was not clearly affected." | 7.88 | Differential effects of clomipramine on depression-like behaviors induced by the chronic social defeat paradigm in tree shrews. ( Duan, Y; Li, M; Li, Y; Liang, J; Meng, X; Qi, K; Shen, F; Sui, N, 2018) |
| "Neonatal rodents chronically treated with the tricyclic antidepressant clomipramine show depression-like behavior, which persists throughout adulthood." | 7.85 | Proteomic investigation of the prefrontal cortex in the rat clomipramine model of depression. ( Baracskay, P; Czurkó, A; Darula, Z; Dobolyi, Á; Gellén, B; Györffy, BA; Hernádi, I; Hunyadi-Gulyás, É; Juhász, G; Kékesi, KA; Völgyi, K, 2017) |
| "The mean concentrations of the pharmacologically active metabolite of clomipramine and desmethylclomipramine changes during pregnancy, where a decrease in mean concentrations was found during pregnancy." | 7.81 | Pharmacokinetics of clomipramine during pregnancy. ( de Jong-van de Berg, LT; Proost, JH; Smit, JP; Ter Horst, PG; Vries, MT; Wilffert, B, 2015) |
| "Using a rat model of CUS-induced depression, we administered clomipramine, one of the typical antidepressants, every day for 3 weeks starting 2 weeks after the beginning of the experiment." | 7.78 | Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression. ( Li, B; Liu, Q; Wang, YQ; Wu, GC; Yu, J; Zhu, HY, 2012) |
| "Neonatal treatment with clomipramine (CMI) in rats induces multiple behavioral alterations during adulthood that resemble certain symptoms of human depression, such as impairments of pleasure-seeking behaviors." | 7.76 | Circadian activity of corticosterone in an animal model of depression: response to muscarinic cholinergic stimulation. ( Arteaga-Silva, M; Bonilla-Jaime, H; Hernández-González, M; Retana-Márquez, S; Vázquez-Palacios, G, 2010) |
| "The aim of the study was to establish if there are differences in the 24-hour melatonin secretion profile between patients with major depression (before, and after treatment with clomipramine) compared to those in healthy subjects." | 7.71 | Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and antidepressant treatment. ( Karasek, M; Rabe-Jablonska, J; Szymanska, A, 2001) |
| "This study examined the integrity of hypothalamic-pituitary-adrenal (HPA) axis in clomipramine model of depression." | 7.70 | Hyperactivity of hypothalamic pituitary axis in neonatal clomipramine model of depression. ( Karanth, KS; Kumar, KB; Prathiba, J, 1998) |
| " The present study controlled these variables by using chloral hydrate anesthesia, testing 'depressed' rats at both 2 and 3 months of age, and verifying electrode location using standard histological techniques." | 7.69 | Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications for endogenous depression. ( Feng, P; Kinney, GG; Vogel, GW, 1997) |
| "Trazodone (TZ) was administered to nine patients suffering from obsessive-compulsive disorder (OCD), who failed to respond to either clomipramine (CMI) or to CMI plus lithium carbonate." | 7.68 | Trazodone treatment in clomipramine-resistant obsessive-compulsive disorder. ( Aizenberg, D; Hermesh, H; Munitz, H, 1990) |
| "In an open, uncontrolled trial flupenthixol was administered to 45 patients with endogenous depression." | 7.65 | Effect of flupenthixol on depression with special reference to combination use with tricyclic antidepressants. An uncontrolled pilot study with 45 patients. ( Baba, O; Fujiwara, J; Hanaoka, M; Ishino, H; Sasaki, K, 1976) |
| "Clonazepam improvement was unrelated to changes in anxiety and occurred early in treatment." | 6.67 | Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder. ( Agras, WS; Hewlett, WA; Vinogradov, S, 1992) |
| " We also examined whether Roman chamomile combined with clomipramine treatment affects hippocampal neurogenesis and serum corticosterone levels." | 5.51 | Roman chamomile inhalation combined with clomipramine treatment improves treatment-resistant depression-like behavior in mice. ( Hashikawa, N; Hashikawa-Hobara, N; Ishikawa, R; Otsuka, A, 2019) |
| "Depression is associated with a deficiency of serotonergic neurons that have been found to suppress orexinergic neurons, which in turn activate these neurons in a feedback loop." | 5.35 | Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine. ( Feng, P; Hu, Y; Strohl, KP; Vurbic, D; Wu, Z, 2008) |
| "The present study was to investigate the effect of electroacupuncture (EA) combined with chlorimipramine on the sucrose preference of depressive rats induced by chronic mild stress (CMS)." | 5.33 | Sucrose preference is restored by electro-acupuncture combined with chlorimipramine in the depression-model rats. ( Cao, XD; Li, XY; Wu, GC; Yu, J, 2006) |
| "Depression is associated with deficiencies in monoaminergic transmitters and possibly neurotrophins." | 5.32 | Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. ( Fang, J; Feng, P; Guan, Z; Yang, X, 2003) |
| "Because metabolites play a major role in the clinical response to clomipramine, the objective of the current study was to develop a population model and evaluate its performance to describe the pharmacokinetic profiles of clomipramine (C) and its active metabolites desmethylclomipramine (DC), 8-hydroxy-clomipramine (OHC) and 8-hydroxy-desmethylclomipramine (OHDC)." | 5.31 | Population pharmacokinetics of clomipramine, desmethylclomipramine, and hydroxylated metabolites in patients with depression receiving chronic treatment: model evaluation. ( Balant, LP; Bechtel, PR; Bizouard, P; Gex-Fabry, M; Haffen, E; Paintaud, G; Sechter, D, 2000) |
| " infusions of Clomipramine in a high dosage, using a fixed therapy schedule with increasing and decreasing dosage ranging from 250 to 500 mg." | 5.26 | [Treatment of therapy resistant depressions with high dose clomipramine]. ( Laux, G; Reimer, F, 1979) |
| " Outpatients suffering from depression (n=74) received the same antidepressant (clomipramine) and were randomized into two groups, receiving either psychodynamic or supportive psychotherapy." | 5.14 | Therapeutic alliance in short-term supportive and psychodynamic psychotherapies: a necessary but not sufficient condition for outcome? ( Andreoli, A; Brunet, A; Burnand, Y; Cailhol, L; Damsa, C; Rodgers, R, 2009) |
| "Ninety-eight depressed patients were prescribed clomipramine in an open flexible manner and followed for depressive symptoms (Montgomery-Asberg depression scale) over a maximum 12 weeks follow-up period." | 5.09 | Clomipramine concentration as a predictor of delayed response: a naturalistic study. ( Balant, LP; Balant-Gorgia, AE; Gex-Fabry, M, 1999) |
| "Thirty outpatients meeting DSM-III-R or DSM-IV criteria for major depression, single or recurrent episode, and failing to respond to an adequate trial of an antidepressant (>6 weeks at recommended dosage) received buspirone (20-30 mg/day) for 4 or 5 weeks in addition to their existing antidepressant." | 5.08 | Buspirone augmentation of antidepressant therapy. ( Dimitriou, CE; Dimitriou, EC, 1998) |
| "To investigate the possibility of chronotherapy with antidepressants for patients with depression, we gave single daily doses of clomipramine 150 mg/day to 30 patients with depression at three different times of day, i." | 5.07 | Double-blind study of the chronopharmacotherapy of depression. ( Ikezaki, A; Nagano, K; Nagayama, H; Tashiro, T, 1991) |
| ") of yohimbine in 12 patients with depression with clomipramine-induced orthostatic hypotension." | 5.06 | Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine. ( Bensimon, G; Diquet, B; Isnard, F; Lacomblez, L; Lecrubier, Y; Puech, AJ, 1989) |
| "On the grounds of different pharmacological properties and possibly different clinical effects, two antidepressants, Anafranil (clomipramine) and Pertofran (desipramine) were compared in the management of depression in general practice." | 5.04 | A comparative trial of Anafranil, Pertofran and an Anafranil/Pertofran combination. ( Murphy, JE, 1977) |
| "In a double-blind study of 24 patients with endogenous depressiona group treated with clomipramine hydrochloride (chlorimipramine) plus tryptophan was compared with a group treated with clomipramine plus placebo." | 5.04 | Potentiation of the antidepressant action of clomipramine by tryptophan. ( Bjorn-Erik, R; Carlsson, A; Nagy, A; Skott, A; Walinder, J, 1976) |
| "The subject of dosage of clomipramine (Anafranil) in depression and in obsessional and phobic disorders is discussed." | 4.75 | Practical considerations on the use of clomipramine (Anafranil) in general practice: an updated review. ( Beaumont, G, 1977) |
| " After oral treatment with clomipramine (50 mg/kg/day) for four weeks, most of the depression-like behaviors were reversed, whereas the motivational reduction was not clearly affected." | 3.88 | Differential effects of clomipramine on depression-like behaviors induced by the chronic social defeat paradigm in tree shrews. ( Duan, Y; Li, M; Li, Y; Liang, J; Meng, X; Qi, K; Shen, F; Sui, N, 2018) |
| "The mean concentrations of the pharmacologically active metabolite of clomipramine and desmethylclomipramine changes during pregnancy, where a decrease in mean concentrations was found during pregnancy." | 3.81 | Pharmacokinetics of clomipramine during pregnancy. ( de Jong-van de Berg, LT; Proost, JH; Smit, JP; Ter Horst, PG; Vries, MT; Wilffert, B, 2015) |
| " We examined whether the administration of clomipramine, a serotonin reuptake inhibitor, to neonatal mice could result in depression-related behavioral alterations in adult mice." | 3.79 | Administration of clomipramine to neonatal mice alters stress response behavior and serotonergic gene expressions in adult mice. ( Ahn, HS; Baik, JH; Kim, JW; Yoon, BJ, 2013) |
| "Neonatal treatment with clomipramine (CMI) in rats induces multiple behavioral alterations during adulthood that resemble certain symptoms of human depression, such as impairments of pleasure-seeking behaviors." | 3.76 | Circadian activity of corticosterone in an animal model of depression: response to muscarinic cholinergic stimulation. ( Arteaga-Silva, M; Bonilla-Jaime, H; Hernández-González, M; Retana-Márquez, S; Vázquez-Palacios, G, 2010) |
| "The present study was designed to evaluate the antidepressant effect of electroacupuncture (EA) and the potential additive or synergistic effects of EA and clomipramine (CLO, a tricyclic antidepressant) in the mouse forced swimming test (FST) and chronic mild stress (CMS) induced depression-model rats." | 3.74 | Electroacupuncture combined with clomipramine enhances antidepressant effect in rodents. ( Cao, XD; Li, XY; Liu, Q; Wang, J; Wang, YQ; Wu, GC; Yu, J, 2007) |
| " She has also been under treatment for obsessive and compulsive neurosis and depression for two years and complained of constipation that was the side effect of the drug clomipramine HCL." | 3.73 | [Case report: taeniasis, is it a cause of psychiatric and neural symptoms?]. ( Aksoy, U; Inceboz, T; Yalçin, G, 2006) |
| " To examine these novel concepts of the pathophysiology of depression and antidepressant medication we have carried out a series of experiments using the chronic psychosocial stress paradigm in male tree shrews, an animal model with a high validity for the pathophysiology of depressive disorders, in which the animals were treated with the tricyclic antidepressant compound clomipramine." | 3.72 | Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews. ( Czéh, B; Flügge, G; Fuchs, E, 2004) |
| "Olfactory bulbectomy, neonatal clomipramine administration, and maternal deprivation have been employed as animal models of depression." | 3.71 | Altered dendritic spine density in animal models of depression and in response to antidepressant treatment. ( Norrholm, SD; Ouimet, CC, 2001) |
| "Clomipramine (CLI), a REM sleep suppressant, alleviates symptoms of depression in adults but produces depressive behaviors if applied neonatally." | 3.71 | Clomipramine suppresses postnatal REM sleep without increasing wakefulness: implications for the production of depressive behaviors. ( Feng, P; Ma, Y, 2002) |
| " In previous studies on rats, we found that neonatal treatment with clomipramine (CLI) during postnatal days 8--21 (P8-21) produced behavioral and physiological abnormalities in adult rats that resembled the abnormalities found in human endogenous depression." | 3.71 | The critical window of brain development from susceptive to insusceptive. Effects of clomipramine neonatal treatment on sexual behavior. ( Feng, P; Ma, Y; Vogel, GW, 2001) |
| "The aim of the study was to establish if there are differences in the 24-hour melatonin secretion profile between patients with major depression (before, and after treatment with clomipramine) compared to those in healthy subjects." | 3.71 | Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and antidepressant treatment. ( Karasek, M; Rabe-Jablonska, J; Szymanska, A, 2001) |
| "Neonatal treatment with clomipramine induces behavioral alterations during adulthood that resemble symptoms observed in human depression." | 3.70 | Pharmacological features of masculine sexual behavior in an animal model of depression. ( Bonilla-Jaime, H; Retana-Marquez, S; Velazquez-Moctezuma, J, 1998) |
| "The effects of substituted benzamides, sulpiride and raclopride on experimental models of depression were studied in male rats after acute or chronic administration in comparison to those of the classical antidepressant, clomipramine." | 3.70 | Effects of acute or chronic administration of substituted benzamides in experimental models of depression in rats. ( Arezzi, A; Drago, F; Virzì, A, 2000) |
| "We report the cases of two patients fulfilling DSM-IV criteria for schizophrenia, who developed a marked depressive symptomatology in the first period of a treatment with clozapine, and were treated successfully with serotonergic drugs (paroxetine, clomipramine)." | 3.70 | Depressive symptomatology during clozapine treatment: two case reports. ( Altamura, AC; Bignotti, S; Curreli, R; Pioli, R; Tura, G, 1998) |
| "This study examined the integrity of hypothalamic-pituitary-adrenal (HPA) axis in clomipramine model of depression." | 3.70 | Hyperactivity of hypothalamic pituitary axis in neonatal clomipramine model of depression. ( Karanth, KS; Kumar, KB; Prathiba, J, 1998) |
| " The present study controlled these variables by using chloral hydrate anesthesia, testing 'depressed' rats at both 2 and 3 months of age, and verifying electrode location using standard histological techniques." | 3.69 | Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications for endogenous depression. ( Feng, P; Kinney, GG; Vogel, GW, 1997) |
| "Trazodone (TZ) was administered to nine patients suffering from obsessive-compulsive disorder (OCD), who failed to respond to either clomipramine (CMI) or to CMI plus lithium carbonate." | 3.68 | Trazodone treatment in clomipramine-resistant obsessive-compulsive disorder. ( Aizenberg, D; Hermesh, H; Munitz, H, 1990) |
| " We report the isolation of Rothia dentocariosa from the blood of a septicaemic patient with chronic lymphocytic leukaemia and bone marrow depression following treatment with clomipramine and zuclopentixol." | 3.67 | Rothia dentocariosa septicaemia in a patient with chronic lymphocytic leukaemia and toxic granulocytopenia. ( Hansen, NE; Jønsson, V; Kristiansen, JE; Pers, C, 1987) |
| "The effects of ECT, amitriptyline, clomipramine, maprotiline and desipramine on the course of endogenous depression were compared in 105 patients using repeated self-administered mood questionnaires as the outcome measure." | 3.66 | Effects of somatic treatments on mood in endogenous depression. ( Albert, W; Klicpera, C; Strian, F, 1979) |
| " Results are given from three studies of clomipramine all failing to demonstrate an association between steady-state plasma clomipramine levels and clinical response both measured as effect--change in severity of depression using the GPCRG rating scale--and side-effect." | 3.66 | Relating plasma levels of clomipramine and clinical response. ( Seldrup, J, 1980) |
| "Plasma concentrations of clomipramine and desmethylclomipramine were monitored together with clinical effects over a period of 1--9 months in children and young adolescents (5--19 years of age) receiving clomipramine because of depressive features or enuresis." | 3.66 | Preliminary observations of the significance of monitoring tricyclic antidepressant plasma levels in the pediatric patient. ( Dugas, M; Durand, G; Leheuzey, MF; Morselli, PL; Rovei, V; Zarifian, E, 1980) |
| "Following the observation that two patients with depression and essential orthostatic hypotension recovered from the latter affection after yohimbine administration, an open study was conducted to assess the activity of yohimbine in correcting orthostatic hypotension induced by tricyclic antidepressants." | 3.66 | [Treatment of orthostatic hypotension induced by tricyclic antidepressants with yohimbine (author's transl)]. ( Allilaire, JF; des Lauriers, A; Lecrubier, Y; Simon, P; Widlocher, D, 1980) |
| " In a study designed to assess plasma levels of clomipramine in twenty-eight patients aged between 65 and 75 years and fourteen patients over 75 years of age and compare them with the levels achieved by a control group of patients aged between 18 and 40 years, the severity of depression was assessed initially and after 7, 14, 21 and 28 days using the General Practitioner Clinical Research Group Scale." | 3.66 | Clomipramine and age: an interaction study. ( Beaumont, G; Poole, P; Watson, JU, 1980) |
| "In an open, uncontrolled trial flupenthixol was administered to 45 patients with endogenous depression." | 3.65 | Effect of flupenthixol on depression with special reference to combination use with tricyclic antidepressants. An uncontrolled pilot study with 45 patients. ( Baba, O; Fujiwara, J; Hanaoka, M; Ishino, H; Sasaki, K, 1976) |
| "The authors, by reference to a patient showing acathisia and other dyskinetic disorders following the administration to him of small doses of metoclopramide (Cerucal) and clomipramine, which is a thymoleptic, discuss extrapyramidal disorders attendant upon the therapy of larvated depressions or depressions accompanied by gastrointestinal disorders." | 3.65 | [Metoclopramide (Cerucal) side-effects in the form of extrapyramidal disorders in combination with an other antidepressive agent]. ( Felber, W; Ficker, F, 1977) |
| " In latent of manifest glaucoma (7 patients) Clomipramine increased the tonography in 1 case, whereas Amitriptyline and Noxiptiline reduced it in 4 cases." | 3.65 | [Psychotropic drugs and glaucoma (author's transl)]. ( Andrée, G; Meiser, H; Schmitt, W, 1976) |
| "In a small series of patients, suffering from obsessional disorders, it was found that there seems to be a type of depression which occurs during the course of clomipramine therapy." | 3.65 | Depressive reactions in the course of clomipramine therapy used in the treatment of obsessional conditions. ( Capstick, N, 1975) |
| "In this study, the pharmacokinetic parameters of the sustained-release (SR) dosage form of clomipramine (CMI) were compared with those obtained after the administration of the immediate-release (IR) dosage form." | 2.69 | Pharmacokinetics of a sustained-release dosage form of clomipramine. ( Galindo, MC; Herrera, D; Jung, H; Mayet, L, 2000) |
| "Serum hormone levels of follicle stimulating hormone (FSH), luteotropic hormone (LH), testosterone (T), prolactin (hPRL), estradiol (E2) and GnRH test were carried out in 11 patients after antidepressive therapy with clomipramine at a dosage of 75 mg/day for 3 months." | 2.67 | Andrological findings in young patients under long-term antidepressive therapy with clomipramine. ( Koinig, G; Maier, U, 1994) |
| "Clonazepam improvement was unrelated to changes in anxiety and occurred early in treatment." | 2.67 | Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder. ( Agras, WS; Hewlett, WA; Vinogradov, S, 1992) |
| "The clomipramine effect was maximum from weeks 10 to 18 and diminished thereafter." | 2.65 | Clomipramine and exposure for obsessive-compulsive rituals: i. ( Cobb, J; Marks, IM; Mawson, D; McDonald, R; Stern, RS, 1980) |
| "In respect of the number of patients : bipolar depressions (10 cases) unipolar (20 cases) it has not been possible to study the results in these 2 sub groups." | 2.64 | [The clomipramine-lithium combination: controlled trial]. ( Des Lauriers, A; Luaute, JP; Moinet, A; Monfort, J; Nick, J, 1976) |
| "Treatment with doxepin is a contraindication to driving during the first two weeks or up to the time when amelioration of symptoms is recorded." | 2.64 | Psychomotor skills in depressed out-patients treated with L-tryptophan, doxepin, or chlorimipramine. ( Linnoila, M; Mattila, MJ; Seppälä, T, 1978) |
| "In the sleep deprivation/chlorimipramine group a quick and long-lasting remission of depressive symptoms could be demonstrated." | 2.64 | [Combined sleep deprivation/chlorimipramine therapy of endogenous depression (author's transl)]. ( Amelung, U; Loosen, PT; Merkel, U, 1976) |
| "Monitoring, prevention, and treatment of hyposalivation induced by antidepressants are encouraged as an adjunct in the clinical management of depression." | 2.40 | Risks for oral health with the use of antidepressants. ( deVries, MW; Peeters, FP; Vissink, A, 1998) |
| "Depression is a highly prevalent concomitant of dementia." | 2.40 | Depression and dementia: comorbidities, identification, and treatment. ( Meyers, BS, 1998) |
| "In addition, depression is characterized by a decreased functioning of the serotonergic system due to changes in the activity or expression of its receptors including, most significantly, 5-HT1A, 5-HT2A, and 5-HT3 in brain regions that regulate mood, emotions, and memory, such as the prefrontal cortex, hippocampus, and amygdala." | 1.91 | Alterations of learning and memory are accompanied by alterations in the expression of 5-HT receptors, glucocorticoid receptor and brain-derived neurotrophic factor in different brain regions of an animal model of depression generated by neonatally male t ( Arteaga-Silva, M; Bonilla-Jaime, H; Cerbón, M; Limón-Morales, O; Molina-Jiménez, T; Morales-Quintero, K, 2023) |
| "Depression has recently been referred to as a neuroimmune disease because it is characterized by inflammatory changes in the cerebral cortex and hippocampus." | 1.51 | Involvement of the microglial NLRP3 inflammasome in the anti-inflammatory effect of the antidepressant clomipramine. ( Gong, W; Halim, M; Li, B; Liu, Q; Ma, L; Ma, Y; Ren, Z; Wang, Y; Yu, J; Zhang, J; Zhang, S; Zhou, G; Zong, Y, 2019) |
| " We also examined whether Roman chamomile combined with clomipramine treatment affects hippocampal neurogenesis and serum corticosterone levels." | 1.51 | Roman chamomile inhalation combined with clomipramine treatment improves treatment-resistant depression-like behavior in mice. ( Hashikawa, N; Hashikawa-Hobara, N; Ishikawa, R; Otsuka, A, 2019) |
| "Depression is a common mental disease affecting a lot of people of all ages around the world." | 1.51 | Zinc improves clomipramine effects on depressive and locomotor behavior and reverses its oxidative stress in rats. ( Abdelmelek, H; Ammari, M; Lassoued, A; Othman, H; Sakly, M, 2019) |
| "Corticosterone levels were increased in the untreated STZ group; SMV and clomipramine significantly decreased corticosterone levels in the STZ groups, but had no effect on the CTR groups." | 1.42 | Antidepressant-like effect of simvastatin in diabetic rats. ( ElBatsh, MM, 2015) |
| "Depression is associated with structural and neurochemical changes in limbic structures, including the hippocampus, that control emotion and mood." | 1.39 | Phospholipase D-mTOR signaling is compromised in a rat model of depression. ( Feng, P; Huang, C, 2013) |
| "The authors present a patient with Gilles de la Tourette syndrome who developed abdominal distension and bloating due to air swallowing." | 1.35 | Air swallowing as a tic. ( Cavanna, AE; Robertson, MM; Weil, RS; Willoughby, JM, 2008) |
| "The present study was to investigate the effect of electroacupuncture (EA) combined with chlorimipramine on the sucrose preference of depressive rats induced by chronic mild stress (CMS)." | 1.33 | Sucrose preference is restored by electro-acupuncture combined with chlorimipramine in the depression-model rats. ( Cao, XD; Li, XY; Wu, GC; Yu, J, 2006) |
| "Depression is associated with deficiencies in monoaminergic transmitters and possibly neurotrophins." | 1.32 | Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine. ( Fang, J; Feng, P; Guan, Z; Yang, X, 2003) |
| "Because metabolites play a major role in the clinical response to clomipramine, the objective of the current study was to develop a population model and evaluate its performance to describe the pharmacokinetic profiles of clomipramine (C) and its active metabolites desmethylclomipramine (DC), 8-hydroxy-clomipramine (OHC) and 8-hydroxy-desmethylclomipramine (OHDC)." | 1.31 | Population pharmacokinetics of clomipramine, desmethylclomipramine, and hydroxylated metabolites in patients with depression receiving chronic treatment: model evaluation. ( Balant, LP; Bechtel, PR; Bizouard, P; Gex-Fabry, M; Haffen, E; Paintaud, G; Sechter, D, 2000) |
| " Moreover, long term administration of both imipramine or SKF 38393 down regulated D1 dopamine receptor number in the prefrontal cortex, while the association of the two drugs resulted in a receptor density similar to that of control rats." | 1.29 | Desensitization of the D1 dopamine receptors in rats reproduces a model of escape deficit reverted by imipramine, fluoxetine and clomipramine. ( Gambarana, C; Ghiglieri, O; Graziella de Montis, M, 1995) |
| "Good results have been obtained in the treatment of depression, and obsessive/compulsive/phobic states, and mixed patients." | 1.26 | Clinical experience in the treatment of obsessional states (2). ( Rack, PH, 1977) |
| " As the reciprocal plasma level during multiple dosing is proportional to the clearance of a compound, this parameter was used for linear regression analysis." | 1.26 | Intraindividual similarity in the metabolism of amitriptyline and chlorimipramine in depressed patients. ( Asberg, M; Bertilsson, L; Mellström, B; Rollins, D; Sjöqvist, F; Träskman, L, 1979) |
| " For eight hours after a single dose plasma clomipramine levels behaved in accordance with known pharmacokinetic principles but thereafter, whichever the route used, there were substantial oscillations, minimal in the morning, maximal early in the afternoon and falling in the late afternoon, peak levels being reached on the second or third day." | 1.26 | Unusual plasma level oscillations of clomipramine in man: a pharmacokinetic and pharmacodynamic dilemma. ( De Cuyper, H; De Zeeuw, RA; Van Praag, HM; Westenberg, HG, 1980) |
| " Their mean clomipramine half-life was 36 hours and mean plasma clomipramine clearance 73 litres per hour, with a wide range in each case." | 1.26 | Single oral dose pharmacokinetics of clomipramine in depressed patients. ( Braithwaite, RA; Dawling, S; McAuley, R; Montgomery, SA, 1980) |
| "Depression was by far the most important factor." | 1.26 | Cortisol in the CSF of depressed and suicidal patients. ( Asberg, M; Bertilsson, L; Lantto, O; Schalling, D; Träskman, L; Tybring, G, 1980) |
| "A series of studies on the pharmacokinetic and pharmacodynamic properties of some tricyclic antidepressants is reviewed." | 1.26 | Treatment of depression with tricyclic drugs--pharmacokinetic and pharmacodynamic aspects. ( Asberg, M, 1976) |
| "Patients showing symptoms of depressive illness were treated in general practice with one of four clomipramine (Anafranil) dosage regimes (25 mg t." | 1.26 | Plasma level studies with clomipramine (anafranil) ( Jones, RB; Luscombe, DK, 1977) |
| " No systemic changes of heart frequency and blood pressure were found during the infusions in spite of the high dosage of tricyclic antidepressants given such a short period as 1 hour." | 1.26 | Investigation of the orthostatic reaction after intravenous administration of imipramine, chlorimipramine, and inimpramine-N-oxide. ( Bake, B; Dencker, SJ, 1976) |
| "An open study of four dosage regimes of clomipramine (Anafranil)--10 mg t." | 1.26 | Comparisons of various clomipramine (Anafranil) dosage regimes. ( Frank, P, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 148 (59.44) | 18.7374 |
| 1990's | 31 (12.45) | 18.2507 |
| 2000's | 39 (15.66) | 29.6817 |
| 2010's | 25 (10.04) | 24.3611 |
| 2020's | 6 (2.41) | 2.80 |
| Authors | Studies |
|---|---|
| Abramova, O | 1 |
| Zorkina, Y | 1 |
| Syunyakov, T | 1 |
| Zubkov, E | 1 |
| Ushakova, V | 1 |
| Silantyev, A | 1 |
| Soloveva, K | 1 |
| Gurina, O | 1 |
| Majouga, A | 1 |
| Morozova, A | 1 |
| Chekhonin, V | 1 |
| Zhang, S | 2 |
| Hu, J | 1 |
| Liu, G | 1 |
| Wu, H | 1 |
| Li, M | 2 |
| Shi, C | 1 |
| Liu, Q | 6 |
| Li, W | 1 |
| Faucher, P | 1 |
| Dries, A | 1 |
| Mousset, PY | 1 |
| Leboyer, M | 1 |
| Dore, J | 1 |
| Beracochea, D | 1 |
| Abdelmeguid, NE | 1 |
| Hammad, TM | 1 |
| Abdel-Moneim, AM | 1 |
| Salam, SA | 1 |
| Limón-Morales, O | 3 |
| Morales-Quintero, K | 1 |
| Arteaga-Silva, M | 4 |
| Molina-Jiménez, T | 2 |
| Cerbón, M | 2 |
| Bonilla-Jaime, H | 6 |
| Rojas-Castañeda, JC | 1 |
| Guadarrama-Cruz, GV | 1 |
| Chakraborty, S | 1 |
| Tripathi, SJ | 1 |
| Raju, TR | 2 |
| Shankaranarayana Rao, BS | 1 |
| Shen, F | 1 |
| Qi, K | 1 |
| Duan, Y | 1 |
| Li, Y | 1 |
| Liang, J | 1 |
| Meng, X | 1 |
| Sui, N | 1 |
| Gong, W | 1 |
| Zong, Y | 1 |
| Halim, M | 1 |
| Ren, Z | 1 |
| Wang, Y | 1 |
| Ma, Y | 3 |
| Li, B | 4 |
| Ma, L | 1 |
| Zhou, G | 1 |
| Yu, J | 6 |
| Zhang, J | 1 |
| Hashikawa-Hobara, N | 1 |
| Otsuka, A | 1 |
| Ishikawa, R | 1 |
| Hashikawa, N | 1 |
| Othman, H | 1 |
| Ammari, M | 1 |
| Lassoued, A | 1 |
| Sakly, M | 1 |
| Abdelmelek, H | 1 |
| Yang, CJ | 1 |
| Yue, N | 1 |
| Liu, Y | 1 |
| Wang, YQ | 4 |
| Wu, GC | 5 |
| Feng, P | 6 |
| Huang, C | 1 |
| Kofune, M | 1 |
| Kofune, T | 1 |
| Ohkubo, K | 1 |
| Watanabe, I | 1 |
| Adebayo, KO | 1 |
| Gureje, O | 1 |
| Nuhu, TF | 1 |
| Piras, G | 3 |
| Piludu, MA | 1 |
| Giorgi, O | 3 |
| Corda, MG | 3 |
| Soria-Fregozo, C | 1 |
| Vázquez-Palacios, G | 3 |
| Wang, J | 2 |
| Chai, A | 1 |
| Zhou, Q | 1 |
| Lv, L | 1 |
| Wang, L | 1 |
| Yang, Y | 1 |
| Xu, L | 2 |
| ElBatsh, MM | 1 |
| Qin, D | 1 |
| Chu, X | 1 |
| Feng, X | 1 |
| Li, Z | 1 |
| Yang, S | 1 |
| Lü, L | 1 |
| Yang, Q | 1 |
| Pan, L | 1 |
| Yin, Y | 1 |
| Li, J | 1 |
| Chen, L | 1 |
| Hu, X | 1 |
| Ter Horst, PG | 1 |
| Proost, JH | 1 |
| Smit, JP | 1 |
| Vries, MT | 1 |
| de Jong-van de Berg, LT | 1 |
| Wilffert, B | 1 |
| Fukushima, N | 1 |
| Nanao, K | 1 |
| Fukushima, H | 1 |
| Namera, A | 1 |
| Miura, M | 1 |
| Gellén, B | 1 |
| Völgyi, K | 1 |
| Györffy, BA | 1 |
| Darula, Z | 1 |
| Hunyadi-Gulyás, É | 1 |
| Baracskay, P | 1 |
| Czurkó, A | 1 |
| Hernádi, I | 1 |
| Juhász, G | 1 |
| Dobolyi, Á | 1 |
| Kékesi, KA | 1 |
| Mao, Q | 1 |
| Huang, Z | 1 |
| Ip, S | 1 |
| Che, C | 1 |
| Kopecek, M | 1 |
| Tislerova, B | 1 |
| Sos, P | 1 |
| Bares, M | 1 |
| Novak, T | 1 |
| Krajca, V | 1 |
| Brunovsky, M | 1 |
| Matrisciano, F | 1 |
| Caruso, A | 1 |
| Orlando, R | 1 |
| Marchiafava, M | 1 |
| Bruno, V | 1 |
| Battaglia, G | 1 |
| Gruber, SH | 1 |
| Melchiorri, D | 1 |
| Tatarelli, R | 1 |
| Girardi, P | 1 |
| Mathè, AA | 1 |
| Nicoletti, F | 1 |
| Vurbic, D | 1 |
| Wu, Z | 1 |
| Hu, Y | 1 |
| Strohl, KP | 1 |
| Kokras, N | 1 |
| Antoniou, K | 1 |
| Dalla, C | 2 |
| Bekris, S | 1 |
| Xagoraris, M | 1 |
| Ovestreet, DH | 1 |
| Papadopoulou-Daifoti, Z | 2 |
| Weil, RS | 1 |
| Cavanna, AE | 1 |
| Willoughby, JM | 1 |
| Robertson, MM | 1 |
| Scinska, A | 1 |
| Swiecicki, L | 1 |
| Korkosz, I | 1 |
| Mierzejewski, P | 1 |
| Kolaczkowski, M | 1 |
| Zhu, HY | 2 |
| Cailhol, L | 1 |
| Rodgers, R | 1 |
| Burnand, Y | 1 |
| Brunet, A | 1 |
| Damsa, C | 1 |
| Andreoli, A | 1 |
| Retana-Márquez, S | 3 |
| Hernández-González, M | 1 |
| Tamburella, A | 1 |
| Micale, V | 4 |
| Leggio, GM | 2 |
| Drago, F | 6 |
| Bhagya, V | 1 |
| Srikumar, BN | 1 |
| Rao, BS | 1 |
| Pitychoutis, PM | 1 |
| Sideris, AC | 1 |
| Tsonis, PA | 1 |
| Lagus, M | 1 |
| Gass, N | 1 |
| Saharinen, J | 1 |
| Savelyev, S | 1 |
| Porkka-Heiskanen, T | 1 |
| Paunio, T | 1 |
| Kim, JW | 1 |
| Ahn, HS | 1 |
| Baik, JH | 1 |
| Yoon, BJ | 1 |
| Mavanji, V | 1 |
| Datta, S | 1 |
| Kudoh, A | 1 |
| Takase, H | 1 |
| Takazawa, T | 1 |
| Lecca, D | 1 |
| Hansson, S | 1 |
| Driscoll, P | 1 |
| Velázquez-Moctezuma, J | 2 |
| Guan, Z | 1 |
| Yang, X | 1 |
| Fang, J | 1 |
| Kordon, A | 1 |
| Broocks, A | 1 |
| Hohagen, F | 1 |
| Fitzpatrick, RE | 1 |
| Persinger, MA | 1 |
| Fuchs, E | 1 |
| Czéh, B | 1 |
| Flügge, G | 1 |
| Consoli, D | 2 |
| Fedotova, J | 1 |
| Sapronov, NS | 1 |
| Inceboz, T | 1 |
| Yalçin, G | 1 |
| Aksoy, U | 1 |
| Yu, GH | 1 |
| Liang, SC | 1 |
| Sun, QZ | 1 |
| Li, XY | 2 |
| Cao, XD | 2 |
| Mazzola, C | 1 |
| Vestergaard, P | 1 |
| Rejnmark, L | 1 |
| Mosekilde, L | 1 |
| Langer, G | 1 |
| Schönbeck, G | 1 |
| Koinig, G | 2 |
| Lesch, O | 1 |
| Schüssler, M | 1 |
| Waldhäusl, W | 1 |
| Brown, WA | 1 |
| Haier, RJ | 1 |
| Qualls, CB | 1 |
| Griffiths, K | 1 |
| Lecrubier, Y | 4 |
| Puech, AJ | 3 |
| Frances, H | 1 |
| Jouvent, R | 2 |
| Widlöcher, D | 3 |
| Simon, P | 3 |
| Kielholz, P | 2 |
| Ridges, AP | 5 |
| Bishop, FM | 2 |
| Lawton, K | 2 |
| Goldberg, IJ | 3 |
| Träskman, L | 5 |
| Tybring, G | 3 |
| Asberg, M | 9 |
| Bertilsson, L | 5 |
| Lantto, O | 1 |
| Schalling, D | 1 |
| van Praag, HM | 5 |
| de Haan, S | 1 |
| Klok, CJ | 1 |
| Brouwer, GJ | 1 |
| Doogan, D | 1 |
| Ross, SB | 1 |
| Aberg-Wistedt, A | 1 |
| Motta, A | 1 |
| Grossi, E | 1 |
| Mavissakalian, M | 1 |
| Michelson, L | 1 |
| Ananth, J | 3 |
| Jørgensen, B | 1 |
| Nørrelund, N | 1 |
| Bech, P | 2 |
| Jakobsen, K | 1 |
| Møller, SE | 1 |
| Reisby, N | 2 |
| Ortmann, J | 2 |
| Elley, J | 2 |
| Krautwald, O | 2 |
| Sgaragli, GP | 2 |
| Ninci, R | 1 |
| Della Corte, L | 2 |
| Borghesi, R | 1 |
| Nardini, M | 1 |
| Battistini, N | 1 |
| Marks, IM | 1 |
| Stern, RS | 1 |
| Mawson, D | 1 |
| Cobb, J | 1 |
| McDonald, R | 1 |
| Borg, V | 1 |
| Gastpar, M | 2 |
| Hobi, V | 1 |
| Pöldinger, W | 1 |
| Goldsmith, S | 1 |
| Maly, V | 1 |
| Schmidlin, PE | 1 |
| Lingjaerde, O | 1 |
| Lemoine, P | 1 |
| Achaintre, A | 1 |
| Balvay, G | 1 |
| Bonnet, H | 1 |
| Burgat, R | 1 |
| Carrier, C | 1 |
| Perrin, J | 1 |
| Valle-Jones, JC | 1 |
| O'Hara, J | 1 |
| O'Hara, H | 1 |
| McGhie, RL | 1 |
| Brodie, NH | 1 |
| Anderson, JA | 1 |
| Schiff, AA | 1 |
| Levin, A | 1 |
| Hullin, RP | 1 |
| Parrack, S | 1 |
| Gringras, M | 2 |
| Beaumont, G | 7 |
| Grieve, A | 2 |
| Watson, JU | 1 |
| Poole, P | 1 |
| Gostick, N | 1 |
| Seldrup, J | 3 |
| John, VA | 1 |
| Luscombe, DK | 8 |
| Kemp, H | 1 |
| Dugas, M | 1 |
| Zarifian, E | 1 |
| Leheuzey, MF | 1 |
| Rovei, V | 1 |
| Durand, G | 1 |
| Morselli, PL | 1 |
| des Lauriers, A | 2 |
| Allilaire, JF | 1 |
| Lapin, A | 1 |
| Karobath, M | 1 |
| Finavera, L | 1 |
| Armocida, G | 1 |
| Majeron, MA | 1 |
| Romerio, C | 1 |
| Dudley, DL | 1 |
| Volberding, N | 1 |
| Loebel, P | 1 |
| Dawling, S | 2 |
| Braithwaite, RA | 2 |
| McAuley, R | 2 |
| Montgomery, SA | 3 |
| De Zeeuw, RA | 1 |
| Westenberg, HG | 1 |
| De Cuyper, H | 1 |
| Moyes, IC | 2 |
| Ray, RL | 1 |
| Moyes, RB | 1 |
| Montgomery, DB | 1 |
| Lewis, P | 1 |
| Rack, PH | 3 |
| Vaddadi, KS | 1 |
| Allen, JJ | 2 |
| John, V | 3 |
| Laux, G | 2 |
| Reimer, F | 2 |
| Maier, U | 1 |
| Jackson, CW | 1 |
| Morton, WA | 1 |
| Lydiard, RB | 1 |
| Hilakivi-Clarke, L | 1 |
| Wright, A | 1 |
| Lippman, ME | 1 |
| Hilakivi-Clarke, LA | 1 |
| Goldberg, R | 1 |
| Gambarana, C | 1 |
| Ghiglieri, O | 1 |
| Graziella de Montis, M | 1 |
| Schlingemann, RO | 1 |
| Smit, AA | 1 |
| Lunel, HF | 1 |
| Hijdra, A | 1 |
| Maudhuit, C | 1 |
| Hamon, M | 1 |
| Adrien, J | 1 |
| Gillman, PK | 1 |
| Kinney, GG | 1 |
| Vogel, GW | 2 |
| Peeters, FP | 1 |
| deVries, MW | 1 |
| Vissink, A | 1 |
| Altamura, AC | 1 |
| Bignotti, S | 1 |
| Tura, G | 1 |
| Curreli, R | 1 |
| Pioli, R | 1 |
| Dwyer, SM | 1 |
| Rosenwasser, AM | 1 |
| Dimitriou, EC | 1 |
| Dimitriou, CE | 1 |
| Prathiba, J | 2 |
| Kumar, KB | 2 |
| Karanth, KS | 2 |
| Gex-Fabry, M | 2 |
| Balant-Gorgia, AE | 2 |
| Balant, LP | 3 |
| Vijayakumar, M | 1 |
| Meti, BL | 1 |
| Meyers, BS | 1 |
| Rosebush, PI | 1 |
| Margetts, P | 1 |
| Mazurek, MF | 1 |
| Nisijima, K | 1 |
| Molina-Hernandez, M | 1 |
| Téllez-Alcántara, P | 2 |
| Srivastava, SK | 1 |
| Nath, C | 1 |
| Arezzi, A | 1 |
| Virzì, A | 1 |
| Haffen, E | 1 |
| Paintaud, G | 1 |
| Bizouard, P | 1 |
| Sechter, D | 1 |
| Bechtel, PR | 1 |
| Herrera, D | 1 |
| Mayet, L | 1 |
| Galindo, MC | 1 |
| Jung, H | 1 |
| Turcotte, JE | 1 |
| Debonnel, G | 1 |
| de Montigny, C | 1 |
| Hébert, C | 1 |
| Blier, P | 1 |
| Jungkun, G | 1 |
| Kuss, HJ | 1 |
| Gsell, W | 1 |
| Nicolosi, A | 1 |
| Lo Menzo, G | 1 |
| Szymanska, A | 1 |
| Rabe-Jablonska, J | 1 |
| Karasek, M | 1 |
| Takamori, K | 1 |
| Yoshida, S | 1 |
| Okuyama, S | 1 |
| Norrholm, SD | 1 |
| Ouimet, CC | 1 |
| Molina, M | 1 |
| Contreras, CM | 1 |
| Kielholz, VP | 1 |
| de Sousa, MP | 1 |
| Lopes, JS | 1 |
| Figueira, L | 1 |
| Cardoso, JN | 1 |
| Ringberger, VA | 1 |
| Sjöqvist, F | 3 |
| Thorén, P | 3 |
| Tuck, JR | 1 |
| Andrejak, M | 1 |
| Fournier, A | 1 |
| Hardin, JM | 1 |
| Coevoet, B | 1 |
| Lambrey, G | 1 |
| De Fremont, JF | 1 |
| Quichaud, J | 1 |
| Walinder, J | 2 |
| Skott, A | 2 |
| Nagy, A | 3 |
| Carlsson, A | 2 |
| Roos, BE | 2 |
| Loosen, PT | 2 |
| Merkel, U | 2 |
| Amelung, U | 2 |
| Wirz-Justice, A | 2 |
| Pühringer, W | 2 |
| Hole, G | 2 |
| Ravizza, L | 2 |
| Moyes, R | 1 |
| Groom, GV | 2 |
| Murphy, JE | 1 |
| Zapletálek, M | 2 |
| Hübsch, T | 1 |
| Zbytovský, J | 1 |
| Polácková, J | 1 |
| Kindernayovä, H | 1 |
| Van Scheyen, JD | 3 |
| Korf, J | 2 |
| Witts, DJ | 3 |
| Mulgirigama, D | 1 |
| Turner, P | 6 |
| Pare, CM | 4 |
| Mulgirigama, LD | 2 |
| Wadsworth, J | 3 |
| Burgess, CD | 1 |
| Kampman, R | 1 |
| Nummikko-Pelkonen, A | 1 |
| Kuha, S | 1 |
| Dencker, SJ | 2 |
| Alfredsson, G | 1 |
| Wiesel, FA | 1 |
| Fyro, B | 1 |
| Sedvall, G | 1 |
| van Kammen, DP | 1 |
| Broadhurst, AD | 2 |
| Filippini, S | 1 |
| Heeley, AF | 2 |
| James, HD | 2 |
| Faravelli, C | 1 |
| Pazzagli, A | 1 |
| Braithwaite, R | 1 |
| Garle, M | 1 |
| Borgå, O | 1 |
| Sacchetti, E | 1 |
| Allaria, E | 1 |
| Negri, F | 1 |
| Biondi, PA | 1 |
| Smeraldi, E | 1 |
| Cazzullo, CL | 1 |
| Cronholm, B | 1 |
| Mellström, B | 2 |
| Neckers, LM | 1 |
| Klicpera, C | 2 |
| Albert, W | 2 |
| Strian, F | 2 |
| Rollins, D | 1 |
| Gram, LF | 2 |
| Sihm, F | 1 |
| Christiansen, J | 1 |
| Risch, SC | 1 |
| Huey, LY | 1 |
| Janowsky, DS | 1 |
| Singh, AN | 1 |
| Sexena, B | 1 |
| Gent, M | 1 |
| Corte, LD | 1 |
| Ehsanullah, RS | 1 |
| Jones, RB | 5 |
| Wright, J | 1 |
| Jain, VK | 1 |
| Terzani, S | 1 |
| Lange, E | 1 |
| Rossner, M | 1 |
| König, L | 1 |
| Ficker, F | 2 |
| Dick, P | 1 |
| Mahy, GE | 1 |
| Seppälä, T | 1 |
| Linnoila, M | 1 |
| Mattila, MJ | 1 |
| Reuter, CJ | 1 |
| Nick, J | 1 |
| Luaute, JP | 1 |
| Moinet, A | 1 |
| Monfort, J | 1 |
| Brock-Utne, JG | 1 |
| Cheetham, RW | 1 |
| Goodwin, NM | 1 |
| Carey, MS | 1 |
| Hawkinson, R | 1 |
| Kornhaber, A | 1 |
| Wellish, CS | 1 |
| Wyndowe, J | 1 |
| Solyom, L | 1 |
| Green, AR | 1 |
| Grahame-Smith, DG | 1 |
| Escobar, JI | 2 |
| Gomez, O | 1 |
| Tuason, VB | 2 |
| Miller, P | 1 |
| Frank, P | 1 |
| Felber, W | 1 |
| Plantey, F | 1 |
| Bake, B | 1 |
| Hallstrom, CO | 1 |
| Rees, WL | 1 |
| Trenchard, A | 1 |
| Shaw, DM | 2 |
| Francis, AF | 1 |
| Williams, P | 1 |
| Williams, R | 1 |
| Link, J | 1 |
| Cole, EN | 1 |
| Hughes, D | 1 |
| Fujiwara, J | 1 |
| Ishino, H | 1 |
| Baba, O | 1 |
| Hanaoka, M | 1 |
| Sasaki, K | 1 |
| Souhami, RL | 1 |
| Ashton, CR | 1 |
| Lee-Potter, JP | 1 |
| Bjorn-Erik, R | 1 |
| Andrée, G | 1 |
| Schmitt, W | 1 |
| Meiser, H | 1 |
| Planche, R | 1 |
| Gathier, MC | 1 |
| Lambert, J | 1 |
| Campbell, P | 1 |
| Ananth, JV | 1 |
| Gomez, L | 1 |
| Pecknold, JC | 3 |
| Amin, MM | 1 |
| Ban, TA | 3 |
| Orbach, L | 1 |
| Gratton, L | 1 |
| Klingner, A | 1 |
| Lehmann, HE | 1 |
| Ashcroft, GW | 1 |
| Capstick, N | 1 |
| Colgan, A | 1 |
| Wootton, LW | 1 |
| Bailey, RI | 1 |
| Macsweeney, DA | 1 |
| Hewland, R | 1 |
| Johnson, AL | 1 |
| Middelburg, ZT | 1 |
| Pazdírek, S | 1 |
| Hanus, H | 1 |
| Teeter, RR | 1 |
| Schiele, BC | 1 |
| Cohen, LJ | 1 |
| Grothe, DR | 1 |
| Nielsen, KK | 1 |
| Brøsen, K | 1 |
| Hewlett, WA | 1 |
| Vinogradov, S | 1 |
| Agras, WS | 1 |
| Sundblad, C | 1 |
| Modigh, K | 1 |
| Andersch, B | 1 |
| Eriksson, E | 1 |
| Anderson, I | 1 |
| Cowen, P | 1 |
| Nagayama, H | 1 |
| Nagano, K | 1 |
| Ikezaki, A | 1 |
| Tashiro, T | 1 |
| Hermesh, H | 1 |
| Aizenberg, D | 1 |
| Munitz, H | 1 |
| Golden, RN | 1 |
| Ruegg, R | 1 |
| Brown, TM | 1 |
| Haggerty, J | 1 |
| Garbutt, JC | 1 |
| Pedersen, CA | 1 |
| Evans, DL | 1 |
| Mavissakalian, MR | 1 |
| Jones, B | 1 |
| Olson, S | 1 |
| Wong, SH | 1 |
| Dellafera, SS | 1 |
| Fernandes, R | 1 |
| Kranzler, H | 1 |
| Turkington, D | 1 |
| Geddes, J | 1 |
| Tapie, M | 1 |
| Garnier, JP | 1 |
| Tremine, T | 1 |
| Bousquet, B | 1 |
| Manet, L | 1 |
| Dreux, C | 1 |
| Lauzel, JP | 1 |
| Pledger, DR | 1 |
| Mathew, H | 1 |
| Dunbar, GC | 1 |
| Naarala, M | 1 |
| Hiltunen, H | 1 |
| Genet, C | 1 |
| Dayer, P | 1 |
| Aeschlimann, JM | 1 |
| Garrone, G | 1 |
| Lacomblez, L | 1 |
| Bensimon, G | 1 |
| Isnard, F | 1 |
| Diquet, B | 1 |
| Vogel, G | 1 |
| Hartley, P | 1 |
| Neill, D | 1 |
| Hagler, M | 1 |
| Kors, D | 1 |
| Pers, C | 1 |
| Kristiansen, JE | 1 |
| Jønsson, V | 1 |
| Hansen, NE | 1 |
| Casas, M | 1 |
| Garcia-Ribera, C | 1 |
| Alvarez, E | 1 |
| Udina, C | 1 |
| Queralto, JM | 1 |
| Grau, JM | 1 |
| Schrader, GD | 1 |
| Levien, HE | 1 |
| Masciocchi, A | 1 |
| Reitano, S | 1 |
| Vanini, M | 1 |
| Cicchetti, V | 1 |
| Smulevich, AB | 1 |
| Vorob'ev, VIu | 1 |
| Zavidovskaia, GI | 1 |
| Lobova, EK | 1 |
| Balashova, MG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effectiveness of the Norepinephrine and Serotonin Reuptake Inhibitor Levomilnacipran in Healthy Males[NCT03249311] | Phase 4 | 36 participants (Actual) | Interventional | 2018-03-02 | Active, not recruiting | ||
| Controlled Trial of Deep Brain Stimulation for Obsessive-Compulsive Disorder[NCT00640133] | Phase 4 | 27 participants (Actual) | Interventional | 2008-03-31 | Active, not recruiting | ||
| Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD[NCT03932773] | Phase 2 | 330 participants (Anticipated) | Interventional | 2019-05-01 | Recruiting | ||
| Randomised Controlled Trial of Neurostimulation for Symptoms of Anorexia Nervosa[NCT05788042] | 70 participants (Anticipated) | Interventional | 2023-08-02 | Recruiting | |||
| A Multisite, Assessor-blinded, Randomized Controlled Trial of Acupuncture for Post-stroke Depression[NCT02644161] | 91 participants (Actual) | Interventional | 2015-10-31 | Completed | |||
| Understanding the Neurocognitive Effects of Fecal Microbiota Transplantation in Major Depressive Disorder Patients With and Without Irritable Bowel Syndrome[NCT05174273] | Phase 2/Phase 3 | 180 participants (Anticipated) | Interventional | 2022-04-06 | Recruiting | ||
| The Safety and Effectiveness of Probiotic Supplementation on Bipolar Depression: a Proof of Concept Randomized Controlled Trial[NCT02155972] | Phase 2 | 16 participants (Actual) | Interventional | 2013-05-31 | Terminated (stopped due to The trial was terminated because of inability to recruit the needed number of participants) | ||
| A Single Ketamine Infusion Combined With Music for Suicidal Ideation During a Depressive Episode: A Randomized Open Label Clinical Trial[NCT04658420] | Phase 2 | 200 participants (Anticipated) | Interventional | 2021-07-01 | Not yet recruiting | ||
| Structural Brain Plasticity in Elderly Depressed Patients Following Electroconvulsive Therapy[NCT02667353] | 110 participants (Actual) | Interventional | 2011-06-30 | Completed | |||
| A Double-Blind, Randomized, Placebo-Controlled Trial of Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder.[NCT00552760] | Phase 4 | 90 participants (Actual) | Interventional | 2007-11-30 | Completed | ||
| Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers[NCT05603819] | 436 participants (Anticipated) | Observational | 2022-06-29 | Recruiting | |||
| The Role of Orexin in Human Panic Disorder[NCT02593682] | Phase 4 | 3 participants (Actual) | Interventional | 2016-05-31 | Completed | ||
| Physical Fitness and Brain - Interventional Study of the Importance of Physical Fitness on Symptoms of Anxiety, Cognitive Ability and Sick Leave, in Primary Care.[NCT03247270] | 168 participants (Actual) | Interventional | 2017-08-21 | Completed | |||
| Novel Neural Circuit Biomarkers of Major Depression Response to Computer-augmented CBT[NCT03096886] | 90 participants (Anticipated) | Interventional | 2017-06-05 | Active, not recruiting | |||
| A Randomized Controlled Trial of the Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Bipolar Disorder[NCT03279224] | Phase 2/Phase 3 | 35 participants (Actual) | Interventional | 2018-01-01 | Active, not recruiting | ||
| Pre-treatment Biomarker for Clinical Response to Neuronavigation Repetitive Transcranial Magnetic Stimulation (rTMS) in the Acute Phase Treatment of Refractory Major Depressive Episode- Role of Intrinsic Functional Connectivity[NCT03348761] | 128 participants (Anticipated) | Interventional | 2015-08-04 | Recruiting | |||
| Imaging Framework for Testing GABAergic/Glutamatergic Drugs in Bipolar Alcoholics[NCT03220776] | Phase 2 | 54 participants (Actual) | Interventional | 2017-08-07 | Completed | ||
| Study of Antidepressants in Parkinson's Disease[NCT00086190] | Phase 3 | 115 participants (Actual) | Interventional | 2005-06-30 | Completed | ||
| Targeted Alterations in n-3 and n-6 Fatty Acids for the Management of Mood Variability in the Maintenance Phase of Bipolar Disorder[NCT02272010] | 83 participants (Actual) | Interventional | 2014-10-31 | Completed | |||
| ED Treatment of Suicidal Patients With Ketamine Infusion[NCT03502551] | Phase 2 | 0 participants (Actual) | Interventional | 2019-04-01 | Withdrawn (stopped due to Trial never received funding.) | ||
| Prediction of the Therapeutic Response in Depression Based on an Early Neuro-computational Modeling Assessment of Motivation[NCT05866575] | 136 participants (Anticipated) | Interventional | 2023-06-01 | Not yet recruiting | |||
| A Safe Ketamine-Based Therapy for Treatment Resistant Depression[NCT01179009] | 20 participants (Actual) | Interventional | 2012-04-30 | Completed | |||
| Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)[NCT01920555] | Phase 2 | 99 participants (Actual) | Interventional | 2014-12-31 | Completed | ||
| The Impact of Spiritual Healing on Moderate Depression in Adults: A Pilot Randomized Controlled Trial (RCT)[NCT04766242] | 28 participants (Anticipated) | Interventional | 2021-03-01 | Not yet recruiting | |||
| Double-blind Trial of Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery[NCT03861988] | Phase 4 | 45 participants (Actual) | Interventional | 2019-08-22 | Completed | ||
| Analisi Dei Marcatori di Stress Ossidativo in Pazienti Affetti da Tumore Della Mammella, Sottoposte a Radioterapia Postoperatoria e Psicoterapia Con Elementi di Musicoterapia[NCT04446624] | 60 participants (Actual) | Interventional | 2018-02-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The Behavioral Activation for Depression Scale (BADS) is a 29-item scale that measures the role of aversive controlling stimuli and escape and avoidance behavior in depression, specifically when and how participants become more activated over the course of treatment. Total scores range from 29-203 and lower scores indicate higher levels of escape and avoidance behavior from depression in the past week. (NCT00640133)
Timeframe: Total BADS score observed means at month-12 time point.
| Intervention | units on a scale (Mean) |
|---|---|
| Active DBS | 85.3 |
| Sham DBS | 80.3 |
A numeric scale (0 through 100) used to rate the social, occupational, and psychological overall functioning during the week of poorest functioning in the past month. Higher scores indicate a higher level of functioning, while low scores indicate impaired global functioning. (NCT00640133)
Timeframe: GAF score observed means at month-12
| Intervention | units on a scale (Mean) |
|---|---|
| Active DBS | 54.8 |
| Sham DBS | 53.7 |
Hamilton Anxiety Rating Scale (HARS) is a 14-item test measuring the severity of anxiety symptoms. It provides measures of overall anxiety, psychic anxiety (mental agitation and psychological distress), and somatic anxiety (physical complaints related to anxiety); total scores range from 0-56. Higher scores indicate higher levels of anxiety over the past week. (NCT00640133)
Timeframe: HARS total score observed means at month-12 time point.
| Intervention | units on a scale (Mean) |
|---|---|
| Active DBS | 12.6 |
| Sham DBS | 15.7 |
The Hamilton Depression Rating Scale (HDRS) measures the severity of depressive symptoms in adults. The evaluator-administered ratings measure depressed mood, guilt, suicide, insomnia, work/activities, retardation, agitation, psychic and somatic anxiety, genital symptoms, hypochondriasis, and insight during the past week. Total scores range from 0-72 and higher scores indicate the presence of more severe depression over the past week. Note: this measure was only administered at baseline and month-3. (NCT00640133)
Timeframe: Total HDRS score observed means at month-3 time point.
| Intervention | units on a scale (Mean) |
|---|---|
| Active DBS | 16.8 |
| Sham DBS | 19.4 |
"The Montgomery Asberg Depression Rating Scale (MADRS) is an interviewer-administered measure assessing the ten symptoms of depression most sensitive to change. Apparent sadness, reported sadness, inner tension, reduced sleep, reduced appetite, concentration difficulties, lassitude, inability to feel, pessimistic thoughts, and suicidal thoughts are assessed and total scores range from 0-60 with higher scores representing the presence of more severe depression over the past week.~interviewer-administered measure assessing" (NCT00640133)
Timeframe: MADRS total score observed means at month-12 time point.
| Intervention | units on a scale (Mean) |
|---|---|
| Active DBS | 17.1 |
| Sham DBS | 18.5 |
The Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) is a self-administered measure to assess the degree of enjoyment and satisfaction experienced by participants in various areas of daily functioning. We used the 16-item short form with total scores ranging from 16-80. Higher scores indicate greater satisfaction experienced during the past week. (NCT00640133)
Timeframe: QLESQ total score observed means at month-12 time point.
| Intervention | units on a scale (Mean) |
|---|---|
| Active DBS | 39.8 |
| Sham DBS | 42.7 |
A numeric scale (0 through 100) used to rate the social, occupational, and psychological functioning during the week of poorest functioning in the past month. Higher scores indicate higher levels of social and occupational functioning, while low scores represent social and occupational impairment. (NCT00640133)
Timeframe: SOFAS score observed means at month-12 time point.
| Intervention | units on a scale (Mean) |
|---|---|
| Active DBS | 55.9 |
| Sham DBS | 53.9 |
The Yale-Brown Obsessive-Compulsive Scale (YBOCS) is a 10 question evaluator-administered measure assessing the severity of obsessions and compulsions over the past week. Obsession and compulsion severity are evaluated separately (ratings from 0-20 for each category) with total scores ranging from 0-40. Higher scores for obsessions, compulsions and total score indicate more severe symptoms over the past week. (NCT00640133)
Timeframe: YBOCS total score observed means at month-12
| Intervention | units on a scale (Mean) |
|---|---|
| Active DBS | 20.5 |
| Sham DBS | 20.9 |
3-part (mania, depression, overall bipolar illness), physician-administered scale used to assess global illness severity; used to measure change. Each part is rated from 1-7, higher scores represent more severe mental illness. Only overall bipolar rating was used. (NCT00552760)
Timeframe: Monthly for 6 months
| Intervention | units on scale (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Baseline | Month 1 | Month 2 | Month 3 | Month 4 | Month 5 | Month 6 | |
| Placebo | 2.15 | 2.25 | 2.90 | 2.93 | 2.98 | 2.99 | 2.41 |
| Ramelteon | 2.14 | 2.29 | 2.24 | 2.53 | 2.36 | 2.46 | 2.54 |
Survival analysis techniques, including Kaplan Meier curves, were used to evaluate group differences in time to relapse. Relapse was defined as a medication initiation or change for manic/depressed/mixed symptoms, a hospitalization for manic/depressed/mixed symptoms, MADRS score >= 16, YMRS score > 14, and suicide risk or imminent risk of suicide. Time to relapse was measured discretely in terms of the number of assessment visits until discontinued from the study. (NCT00552760)
Timeframe: Monthly for 6 months
| Intervention | Cumulative proportion of participants (Number) | ||||||
|---|---|---|---|---|---|---|---|
| Baseline | Month 1 | Month 2 | Month 3 | Month 4 | Month 5 | Month 6 | |
| Placebo | 1.00 | 0.951 | 0.588 | 0.448 | 0.384 | 0.320 | 0.320 |
| Ramelteon | 1.00 | 0.929 | 0.849 | 0.716 | 0.661 | 0.632 | 0.566 |
10-item, standardized, well-validated scale used to measure severity of depressive symptoms; sensitive to treatment effects in depressed outpatients. Scores range from 0-60, higher scores represent more severe depressive symptoms. (NCT00552760)
Timeframe: Monthly for 6 months
| Intervention | units on scale (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Baseline | Month 1 | Month 2 | Month 3 | Month 4 | Month 5 | Month 6 | |
| Placebo | 8.27 | 8.90 | 11.13 | 11.85 | 13.03 | 11.59 | 10.46 |
| Ramelteon | 7.79 | 8.34 | 7.23 | 9.17 | 8.45 | 8.56 | 10.40 |
Self-rated scale to measure quality of sleep via questions regarding sleep latency, duration, efficiency, disturbances, use of sleep medication, and daytime dysfunction. Scores range from 0-21, higher scores represent more significant sleep disturbance. (NCT00552760)
Timeframe: Monthly for 6 months
| Intervention | units on scale (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Baseline | Month 1 | Month 2 | Month 3 | Month 4 | Month 5 | Month 6 | |
| Placebo | 10.88 | 9.28 | 9.71 | 10.38 | 9.03 | 8.66 | 8.76 |
| Ramelteon | 10.17 | 8.16 | 7.93 | 7.89 | 7.21 | 6.62 | 6.90 |
11-item standardized, well-validated scale used to measure manic symptoms; sensitive to treatment effects in manic patients. Scores range from 0-60, higher scores represent more severe manic symptoms. (NCT00552760)
Timeframe: Monthly for 6 months
| Intervention | units on scale (Mean) | ||||||
|---|---|---|---|---|---|---|---|
| Baseline | Month 1 | Month 2 | Month 3 | Month 4 | Month 5 | Month 6 | |
| Placebo | 6.59 | 6.46 | 7.75 | 8.09 | 4.95 | 5.71 | 6.72 |
| Ramelteon | 7.02 | 5.89 | 5.91 | 6.60 | 5.93 | 5.18 | 6.51 |
Concentrations of GABA+, referenced to unsuppressed water and corrected for within-voxel CSF proportion, in dorsal anterior cingulate cortex measured via Proton Magnetic Resonance Spectroscopy (i.e., MEGA-PRESS). (NCT03220776)
Timeframe: Day 5 of each experimental condition
| Intervention | mmol/kg (Mean) |
|---|---|
| N-Acetylcysteine | 3.90 |
| Gabapentin | 3.93 |
| Placebo Oral Tablet | 3.73 |
Concentrations of Glx (i.e., glutamate + glutamine), referenced to unsuppressed water and corrected for within-voxel CSF proportion, in dorsal anterior cingulate cortex measured via Proton Magnetic Resonance Spectroscopy. (NCT03220776)
Timeframe: Day 5 of each experimental condition
| Intervention | mmol/kg (Mean) |
|---|---|
| N-Acetylcysteine | 21.59 |
| Gabapentin | 21.69 |
| Placebo Oral Tablet | 22.25 |
Beck Depression Inventory II ranges from 0-63. Higher score indicates more severe depression. 0-13 minimal depression, 14-19 mild depression, 20-28 moderate depression, 29-63 severe depression. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in BDI-II score (Mean) |
|---|---|
| Paroxetine | -9.7 |
| Venlafaxine Extended Release | -9.6 |
| Placebo | -5.2 |
Brief Psychiatric Rating Scale. Maximum score 126. Higher score indicates greater psychiatric difficulties. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in BPRS score (Mean) |
|---|---|
| Paroxetine | -9.0 |
| Venlafaxine Extended Release | -9.8 |
| Placebo | -4.4 |
Geriatric Depression Scale ranges from 0-30. Higher score indicates more severe depression. 0-9 normal, 10-19 mild depression, 20-30 severe depression. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in GDS score (Mean) |
|---|---|
| Paroxetine | -6.9 |
| Venlafaxine Extended Release | -6.9 |
| Placebo | -2.8 |
Change in Hamilton Rating Scale for Depression over 12 weeks. Hamilton Depression Rating Scale ranges from 0-50. Higher scores represent more significant depression. Mild depression ranges from 8-13, moderate depression from 14-18, severe 19-22 and very severe any score over 23. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in HAM-D score (Mean) |
|---|---|
| Paroxetine | -13.0 |
| Venlafaxine Extended Release | -11.0 |
| Placebo | -6.8 |
Montgomery-Asberg Depression Rating Scale ranges from 0-60. Higher score indicates more severe depression. 0-6 normal, 7-19 mild depression, 20-34 moderate depression, greater than 34 severe depression. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in MADRS score (Mean) |
|---|---|
| Paroxetine | -13.6 |
| Venlafaxine Extended Release | -10.9 |
| Placebo | -6.6 |
Parkinson's Disease Questionnaire (PDQ-39) - Emotional Well-Being maximum score 24, minimum score of 0.Lower score indicates a better perceived health status. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in PDQ-39 Emotional score (Mean) |
|---|---|
| Paroxetine | -21.4 |
| Venlafaxine Extended Release | -20.7 |
| Placebo | -10.9 |
Parkinson's Disease Questionnaire (PDQ-39) Total. Range 0-100. Lower score indicates a better perceived health status. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in PDQ-39 score (Mean) |
|---|---|
| Paroxetine | -8.0 |
| Venlafaxine Extended Release | -8.4 |
| Placebo | -5.3 |
Pittsburgh Sleep Quality Index scores range from 0-21, with higher scores indicating severe sleep difficulties. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in PQSI score (Mean) |
|---|---|
| Paroxetine | -2.1 |
| Venlafaxine Extended Release | -2.6 |
| Placebo | -1.1 |
Short Form 36 Health Survey. Range 0-100. Higher score indicates a better perceived quality of life. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in SF-36 mental score (Mean) |
|---|---|
| Paroxetine | 11.4 |
| Venlafaxine Extended Release | 9.5 |
| Placebo | 4.8 |
Short Form 36 Health Survey - Mental Health subscale ranges from 0-100. Higher score indicates a better perceived quality of life. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in SF-36 Mental Health score (Mean) |
|---|---|
| Paroxetine | 16.7 |
| Venlafaxine Extended Release | 17.4 |
| Placebo | 9.7 |
Short Form 36 Health Survey - Emotional subscale ranges from 0-100. Higher score indicates a better perceived quality of life. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in SF-36 Role score (Mean) |
|---|---|
| Paroxetine | 39.5 |
| Venlafaxine Extended Release | 26.9 |
| Placebo | 12.7 |
Short Form 36 Health Survey - Vitality subscale ranges from 0-100. Higher score indicates a better perceived quality of life. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in SF-36 vitality score (Mean) |
|---|---|
| Paroxetine | 13.5 |
| Venlafaxine Extended Release | 9.1 |
| Placebo | 4.7 |
Snaith Clinical Anxiety Scale. Range 0-21. Higher scores indicate increased anxiety. Score greater than 8 indicates clinical anxiety. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in CAS score (Mean) |
|---|---|
| Paroxetine | -3.6 |
| Venlafaxine Extended Release | -3.2 |
| Placebo | -2.4 |
Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum = 0. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in UPDRS score (Mean) |
|---|---|
| Paroxetine | -8.7 |
| Venlafaxine Extended Release | -7.0 |
| Placebo | -4.3 |
Unified Parkinson's Disease Rating Scale - Bulbar maximum score 24, minimum score of 0. Higher score indicates more severe Parkinson's disease symptoms. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in UPDRS-Bulbar score (Mean) |
|---|---|
| Paroxetine | -1.4 |
| Venlafaxine Extended Release | -1.4 |
| Placebo | -0.5 |
Unified Parkinson's Disease Rating Scale - Motor has a maximum score of 72, minimum score of 0. Higher score indicates more severe Parkinson's disease symptoms. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in UPDRS-motor score (Mean) |
|---|---|
| Paroxetine | -4.3 |
| Venlafaxine Extended Release | -2.0 |
| Placebo | -1.0 |
Unified Parkinson's Disease Rating Scale - Tremor subscale ranges from 0-23. Higher score indicates more severe Parkinson's disease symptoms. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in UPDRS-tremor score (Mean) |
|---|---|
| Paroxetine | 0.4 |
| Venlafaxine Extended Release | 0.5 |
| Placebo | -0.6 |
The Montgomery-Asberg Depression Rating Scale (MADRS) is a 10-item scale that measures the severity of depression, with a higher score indicating a higher level of depression. The range of scores is 0 to 60. (NCT01179009)
Timeframe: 8 weeks
| Intervention | Scores on a scale (Mean) |
|---|---|
| Ketamine 100-hour Infusion | -9.0 |
| Ketamine 40-minute Infusion | -6.4 |
"The CGI-I is a clinician rated single-item scale: Compared to the patient's condition at admission, how much has the patient changed?, rated on a 7-point response scale: 1 = Very much improved, 2 = Much improved, 3 = Minimally improved, 4 = No change, 5 = Minimally worse, 6 = Much worse, and 7 = Very much worse. In this case, admission referred to the CGI-S screening assessments performed between Day -28 an -7, one conducted during the screening visit, and a second rating conducted by a remote, independent rater." (NCT01920555)
Timeframe: A baseline assessment was made on Day 0, preceding infusion (i.e., treatment). Outcome assessments were made on days 1, 3, 5, 7, 14, and 30. The primary endpoint for this study was Day 3. Thus, the outcome measure table provides data on Days 0, 1 and 3
| Intervention | units on a scale (Mean) | ||
|---|---|---|---|
| Day 0 | Day 1 | Day 3 | |
| Ketamine 0.1mg | 3.8888889 | 3.0625000 | 2.9333333 |
| Ketamine 0.2mg | 4.0500000 | 3.3684211 | 2.8421053 |
| Ketamine 0.5mg | 4.1363636 | 2.6363636 | 2.5714286 |
| Ketamine 1.0mg | 4.0000000 | 3.0500000 | 2.5500000 |
| Midazolam 0.045mg | 4.1578947 | 3.6111111 | 3.1666667 |
"The CGI-S is a clinician rated single-item scale: How depressed is the patient at this time?, rated on a 7-point response scale: 1 = Normal, not at all depressed, 2 = Borderline depressed, 3 = Mildly depressed, 4 = Moderately depressed. 5 = Markedly depressed, 6 = severely depressed, 7 = Among the most severely depressed patients. When rating patients, clinicians were asked to consider the past 24 hours." (NCT01920555)
Timeframe: A baseline assessment was made on Day 0, preceding infusion (i.e., treatment). Outcome assessments were made on days 1, 3, 5, 7, 14, and 30. The primary endpoint for this study was Day 3. Thus, the outcome measure table provides data on Days 0, 1 and 3
| Intervention | units on a scale (Mean) | ||
|---|---|---|---|
| Day 0 | Day 1 | Day 3 | |
| Ketamine 0.1mg | 5.0000000 | 3.5625000 | 3.4000000 |
| Ketamine 0.2mg | 5.2000000 | 4.2631579 | 3.7368421 |
| Ketamine 0.5mg | 4.8636364 | 3.2727273 | 3.1428571 |
| Ketamine 1.0mg | 5.2000000 | 3.5000000 | 3.3000000 |
| Midazolam 0.045mg | 5.000000 | 4.555556 | 4.1666667 |
"The CPAS is a 16-item self-report scale to assess the level to which participants experience persistent distress due to feeling that they have not returned to their normal or premorbid state. Items (e.g., I look forward to things) are rated on a 5-point scale (0=not at all, 1=very much less than normal, 2=much less than normal, 3=slightly less than normal, 4=same as best or normal self). The possible scale range is 0 to 64, with higher scores indicating greater recovery from depression. Patients were asked to rate their experience of the past 24 hours." (NCT01920555)
Timeframe: A baseline assessment was made on Day 0, preceding infusion (i.e., treatment). Outcome assessments were made on days 1, 3, 5, 7, 14, and 30. The primary endpoint for this study was Day 3. Thus, the outcome measure table provides data on Days 0, 1 and 3
| Intervention | units on a scale (Mean) | ||
|---|---|---|---|
| Day 0 | Day 1 | Day 3 | |
| Ketamine 0.1mg | 19.3333333 | 35.2500000 | 38.8666667 |
| Ketamine 0.2mg | 20.5000000 | 27.0526316 | 28.3888889 |
| Ketamine 0.5mg | 20.6363636 | 40.8696964 | 39.7619048 |
| Ketamine 1.0mg | 21.2500000 | 33.0000000 | 37.4500000 |
| Midazolam 0.045mg | 21.2631579 | 24.4444444 | 33.3750000 |
"The CADSS is a 23-item self-report scale for the assessment of dissociative states. It is a reliable, valid self-report instrument. The severity of each dissociative symptom ranges from 0 (not present) to 4 (extreme). The total score is calculated by summing across items, with a total possible range of 0-92. The CADSS was administered right before infusion, and 40, 80 minute and 120 minutes after the start of infusion. The timeframe is at this moment." (NCT01920555)
Timeframe: Day 0/baseline at 0, 40, 80, and 120 minutes
| Intervention | units on a scale (Mean) | |||
|---|---|---|---|---|
| Minute 0 | Minute 40 | Minute 80 | Minute 120 | |
| Ketamine 0.1mg | 0.1111111 | 3.0000000 | 0.4444444 | 0.0555556 |
| Ketamine 0.2mg | 0.1000000 | 4.0500000 | 0.1000000 | 0 |
| Ketamine 0.5mg | 0 | 14.2727273 | 0.7727273 | 0.1363636 |
| Ketamine 1.0mg | 0.1000000 | 24.6842105 | 1.8000000 | 0.6500000 |
| Midazolam 0.045mg | 0.4210526 | 2.6842105 | 1.1578947 | 0.5789474 |
The HAMD6 is a 6-item clinician-rated scale, where clinicians rate the presence of depression symptoms (i.e., depressed mood, guilt, work and interests, psychomotor retardation, psychic anxiety, somatic symptoms) on a 5-point scale, where 0 = not present, and 1-4 represent increasingly severe symptoms. One item (i.e., somatic symptoms) is rated on only a 3-point scale, ranging from 0-2. The possible scale range is 0-22, where higher values represent more severe depression. This instrument is completed with a structured interview guide by the clinician based on his/her assessment of the patient's symptoms. This structured interview has been validated for use with time frames shorter than one week. In this study, the HAMD6 was used to assess symptoms occurring in the past 24 hours. (NCT01920555)
Timeframe: A baseline assessment was made on Day 0, preceding infusion (i.e., treatment). Outcome assessments were made on days 1, 3, 5, 7, 14, and 30. The primary endpoint for this study was Day 3. Thus, the outcome measure table provides data on Days 0, 1, & 3
| Intervention | units on a scale (Mean) | ||
|---|---|---|---|
| Day 0 | Day 1 | Day 3 | |
| Ketamine 0.1mg | 12.5555556 | 7.5000000 | 6.8000000 |
| Ketamine 0.2mg | 12.7500000 | 9.2631579 | 8.4736842 |
| Ketamine 0.5mg | 12.5909091 | 5.8636364 | 5.9047619 |
| Ketamine 1.0mg | 12.6315789 | 6.9000000 | 7.2000000 |
| Midazolam 0.045mg | 13.0526316 | 10.6666667 | 9.0555556 |
"The MADRS is a 10-item clinician-rated scale measuring depression severity. Symptoms are rated on a 7-point scale, where 0 = not present, and 1-6 represent increasing severity. Values 2, 4, and 6 have specific anchoring text (e.g., 2=Difficulties in starting activities. 4=Difficulties in starting simple routine activities which are carried out with effort, 6=Complete lassitude. Unable to do anything without help.) Values 1, 3, and 5 do not have specific text. The possible scale range is 0-60, where higher values represent higher severity. In this study, the MADRS was used to rate symptoms occurring in the past 3 days." (NCT01920555)
Timeframe: A baseline assessment was made on Day 0, preceding infusion (i.e., treatment). Outcome assessments were made on days 3, 5, 7, 14, and 30. The primary endpoint for this study was Day 3. Thus, the outcome measure table provides data on Days 0 and 3.
| Intervention | units on a scale (Mean) | |
|---|---|---|
| Day 0 | Day 3 | |
| Ketamine 0.1mg | 33.8333333 | 19.6666667 |
| Ketamine 0.2mg | 34.4500000 | 22.6315789 |
| Ketamine 0.5mg | 31.5909091 | 14.7619048 |
| Ketamine 1.0mg | 32.6500000 | 17.1000000 |
| Midazolam 0.045mg | 33.6315789 | 24.8333333 |
The Columbia Suicide Severity Rating Scale (C-SSRS): The C-SSRS is a low-burden measure of the spectrum of suicidal ideation and behavior that was developed in the National Institute of Mental Health Treatment of Adolescent Suicide Attempters Study to assess severity and track suicidal events through any treatment. It is a clinical interview providing a summary of both ideation and behavior that can be administered during any evaluation or risk assessment to identify the level and type of suicidality present. The C-SSRS can also be used during treatment to monitor for clinical worsening or improvement. It contains 5 rating scale questions (yes/no) for suicidal ideation increasing severity and 5 rating scale questions (yes/no) for suicidal behavior of increasing severity. The time frame is for both lifetime and the past six months for the Baseline/Screening scale and since the last visit for the Since Last Visit scale. (NCT01920555)
Timeframe: Screening Visit and Days 0, 1, 3, 5, 7, 14 and 30 combined
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Screening: # with suicidal ideation/behavior | Follow-Up: # with suicidal ideation/behavior | |
| Ketamine 0.1mg | 17 | 15 |
| Ketamine 0.2mg | 15 | 9 |
| Ketamine 0.5mg | 17 | 10 |
| Ketamine 1.0mg | 14 | 6 |
| Midazolam 0.045mg | 17 | 13 |
"CBC~Chemistry (Total bilirubin, AST, ALT, GGT, ALK Phosphatase, Creatinine, BUN/Urea, Glucose, Uric Acid)~Testing was performed by study site laboratories and used institutional normal lab value ranges." (NCT01920555)
Timeframe: Day 3 and Early Termination Visit (approximately 3 weeks following intervention)
| Intervention | Participants (Count of Participants) | ||||
|---|---|---|---|---|---|
| Chemistry ALT(SGPT) | Chemistry AST(SGOT) | Chemistry Total Bilirubin | Chemistry Remaining Tests | CBC | |
| Ketamine 0.1mg | 0 | 0 | 0 | 0 | 0 |
| Ketamine 0.2mg | 1 | 1 | 1 | 0 | 0 |
| Ketamine 0.5mg | 0 | 0 | 0 | 0 | 0 |
| Ketamine 1.0mg | 0 | 0 | 0 | 0 | 0 |
| Midazolam 0.045mg | 0 | 0 | 0 | 0 | 0 |
"The SHAPS is a 14-item self-report scale to measure hedonic tone. Items (e.g., I would enjoy reading a book, magazine, or newspaper.) are rated on a 4-point scale (1=strongly disagree, 2=disagree, 3=agree, 4=strongly agree). Either of the 'disagree' responses scores 1 point, and either of the 'agree' responses scores 0 points, for a total scale range of 0-14. Higher scores indicate greater inability to experience pleasure. Patients were asked to rate their experience of the past 24 hours." (NCT01920555)
Timeframe: A baseline assessment was made on Day 0, preceding infusion (i.e., treatment). Outcome assessments were made on days 1, 3, 5, 7, 14, and 30. The primary endpoint for this study was Day 3. Thus, the outcome measure table provides data on Days 0, 1 and 3
| Intervention | units on a scale (Mean) | ||
|---|---|---|---|
| Day 0 | Day 1 | Day 3 | |
| Ketamine 0.1mg | 7.2222222 | 3.9375000 | 3.5333333 |
| Ketamine 0.2mg | 7.5500000 | 5.7368421 | 6.3888889 |
| Ketamine 0.5mg | 6.5909091 | 2.22727273 | 3.0000000 |
| Ketamine 1.0mg | 7.3500000 | 4.3000000 | 3.6500000 |
| Midazolam 0.045mg | 6.4736842 | 5.0000000 | 4.2500000 |
"The SDQ is a 44-item self-report scale, which aims to measure depression more comprehensively by including the assessment of symptoms in the anxiety-depression spectrum, including symptoms of irritability, anger attacks, and anxiety. Items are rated on an 6-point Likert scale, where participants are asked to rate if a specific symptom (e.g. How has your mood been over the past 24 hours?) is normal for him or her (score = 2), what is better than normal (score = 1), and what is worse than normal (scores = 3-6). The total scale score is calculated by averaging across the items, resulting in a possible range from 1 to 6. Higher scores indicate greater depression severity. When rating, patients were asked to consider their symptoms during the past 24 hours." (NCT01920555)
Timeframe: A baseline assessment was made on Day 0, preceding infusion (i.e., treatment). Outcome assessments were made on days 1, 3, 5, 7, 14, and 30. The primary endpoint for this study was Day 3. Thus, the outcome measure table provides data on Days 0, 1 and 3
| Intervention | units on a scale (Mean) | ||
|---|---|---|---|
| Day 0 | Day 1 | Day 3 | |
| Ketamine 0.1mg | 3.5164141 | 2.5752843 | 2.5106061 |
| Ketamine 0.2mg | 3.4636364 | 2.9096195 | 2.7828283 |
| Ketamine 0.5mg | 3.5392562 | 2.3109504 | 2.5573593 |
| Ketamine 1.0mg | 3.4113636 | 2.6113636 | 2.5909091 |
| Midazolam 0.045mg | 3.4264507 | 2.9200573 | 2.8751353 |
Number of days from admission (day of surgery) through discharge after surgery. (NCT03861988)
Timeframe: Average approximately 3 days post-intervention
| Intervention | days (Mean) |
|---|---|
| Open Label Ketamine | 3.7 |
| Double Blind Ketamine | 1.9 |
| Double Blind Placebo | 4.0 |
Remission defined as a MADRS score of <=12 on day 14. MADRS score range: 0 to 60, a lower score indicates lower severity of symptoms. (NCT03861988)
Timeframe: Post-intervention day 14
| Intervention | Participants (Count of Participants) |
|---|---|
| Open Label Ketamine | 3 |
| Double Blind Ketamine | 8 |
| Double Blind Placebo | 10 |
"Average pain intensity in the past 24 hours, rated on a numerical scale from 0 to 10 (with 0 representing No pain and 10 representing Pain as bad as you can imagine)." (NCT03861988)
Timeframe: Post-intervention days 1, 2, 3, 5, 7 and 14
| Intervention | score on a scale (Mean) | |||||
|---|---|---|---|---|---|---|
| Day 1 | Day 2 | Day 3 | Day 5 | Day 7 | Day 14 | |
| Double Blind Ketamine | 6.0 | 5.3 | 5.5 | 5.5 | 5.1 | 4.8 |
| Double Blind Placebo | 5.2 | 6.0 | 5.2 | 4.4 | 4.4 | 3.7 |
| Open Label Ketamine | 4.6 | 5.5 | 3.5 | 4.4 | 4.8 | 4.4 |
"Pain interference in the past 24 hours, rated on a numerical scale from 0 to 10 (with 0 representing Does not interfere and 10 representing Completely interferes)." (NCT03861988)
Timeframe: Post-intervention days 1, 2, 3, 5, 7 and 14
| Intervention | units on a scale (Mean) | |||||
|---|---|---|---|---|---|---|
| Day 1 | Day 2 | Day 3 | Day 5 | Day 7 | Day 14 | |
| Double Blind Ketamine | 8.1 | 8.0 | 7.5 | 7.0 | 6.7 | 6.2 |
| Double Blind Placebo | 7.6 | 8.1 | 7.7 | 7.0 | 7.2 | 5.7 |
| Open Label Ketamine | 6.0 | 6.3 | 4.8 | 6.6 | 7.6 | 4.8 |
This outcome measures how many cumulative morphine-equivalents milligrams of opioid pain medication the patient has taken as an inpatient and after discharge from hospital (NCT03861988)
Timeframe: Post-intervention days 1, 2, 3, 5, 7 and 14
| Intervention | milligram morphine equivalents (Mean) | ||
|---|---|---|---|
| Day 1 | Day 2 | Day 3 | |
| Open Label Ketamine | 108.5 | 249.3 | 361.5 |
This outcome measures how many cumulative morphine-equivalents milligrams of opioid pain medication the patient has taken as an inpatient and after discharge from hospital (NCT03861988)
Timeframe: Post-intervention days 1, 2, 3, 5, 7 and 14
| Intervention | milligram morphine equivalents (Mean) | |||||
|---|---|---|---|---|---|---|
| Day 1 | Day 2 | Day 3 | Day 5 | Day 7 | Day 14 | |
| Double Blind Ketamine | 60.9 | 104.6 | 137.9 | 150.6 | 171.6 | 206.1 |
| Double Blind Placebo | 56.1 | 107.7 | 144.3 | 156.2 | 163.3 | 186.4 |
This outcome measures self-reported symptoms of anxiety and depression on a scale that ranges from 0 to 42. A lower score indicates lower severity of symptoms. (NCT03861988)
Timeframe: Post-intervention days 1, 2, 3, 5, 7 and 14
| Intervention | score on a scale (Mean) | |||||
|---|---|---|---|---|---|---|
| Day 1 | Day 2 | Day 3 | Day 5 | Day 7 | Day 14 | |
| Double Blind Ketamine | 17.8 | 18.8 | 19.3 | 18.3 | 18.4 | 16.4 |
| Double Blind Placebo | 19.9 | 21.2 | 20.8 | 18.9 | 19.6 | 17.2 |
| Open Label Ketamine | 14.8 | 22.6 | 13.0 | 16.6 | 19.2 | 14.0 |
The MADRS is a 10-item scale for the evaluation of depressive symptoms (Montgomery et al 1979). Each MADRS item is rated on a 0 to 6 scale. Total score range from 0-60, where lower MADRS scores indicate lower levels of depressive symptoms. The assessment for this outcome will be taken once daily on days 1, 2 and 3 post procedure. A mixed model for repeated measures (MMRM) was used to analyze the difference in postoperative MADRS score between ketamine and placebo groups.. (NCT03861988)
Timeframe: Post-intervention days 1, 2 and 3
| Intervention | score on a scale (Mean) | ||
|---|---|---|---|
| Day 1 | Day 2 | Day 3 | |
| Double Blind Ketamine | 12.7 | 15.1 | 17.0 |
| Double Blind Placebo | 16.4 | 17.5 | 17.2 |
| Open Label Ketamine | 17.0 | 25.4 | 10.5 |
Clinical response defined as >=50% reduction in MADRS score from baseline. MADRS score range: 0 to 60, a lower score indicates lower severity of symptoms. (NCT03861988)
Timeframe: Post-intervention days 1, 2 and 3
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Day 1 | Day 2 | Day 3 | |
| Double Blind Ketamine | 12 | 10 | 9 |
| Double Blind Placebo | 10 | 12 | 10 |
| Open Label Ketamine | 2 | 1 | 3 |
14 reviews available for clomipramine and Depression
| Article | Year |
|---|---|
Body dysmorphic disorder in a Nigerian boy presenting as depression: a case report and literature review.
Topics: Adolescent; Body Dysmorphic Disorders; Clomipramine; Depression; Diagnosis, Differential; Humans; Ma | 2012 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Age | 2003 |
[Current treatment of depression].
Topics: Administration, Oral; Antidepressive Agents; Antipsychotic Agents; Clomipramine; Depression; Depress | 1983 |
Central serotonin deficiency--a factor which increases depression vulnerability?
Topics: 5-Hydroxytryptophan; Adult; Biogenic Amines; Brain Chemistry; Clomipramine; Depression; Female; Huma | 1980 |
Clomipramine in obsessive-compulsive disorder: a review.
Topics: Behavior Therapy; Clomipramine; Depression; Double-Blind Method; Humans; Obsessive Behavior; Obsessi | 1983 |
Antidepressants and the serotonin uptake in platelets.
Topics: Amitriptyline; Antidepressive Agents; Blood Platelets; Brain; Clomipramine; Depression; Dose-Respons | 1980 |
Risks for oral health with the use of antidepressants.
Topics: Antidepressive Agents; Clomipramine; Dental Caries; Depression; Diagnosis, Differential; Humans; Mal | 1998 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cog | 1998 |
A review of the relationship between endocrinopathy and depression or antidepressant drugs, with particular respect to novel theories involving the opiate receptor.
Topics: Circadian Rhythm; Clomipramine; Depression; Dibenzazepines; Endorphins; Enkephalins; Hormones; Human | 1977 |
Practical considerations on the use of clomipramine (Anafranil) in general practice: an updated review.
Topics: Clomipramine; Depression; Dibenzazepines; Drug Interactions; Female; Humans; Male; Phobic Disorders; | 1977 |
A review of the CNS effects of fenfluramine, 780SE and norfenfluramine on animals and man.
Topics: Acetylcholine; Amphetamine; Analgesia; Animals; Behavior; Biogenic Amines; Body Temperature Regulati | 1975 |
Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine.
Topics: Animals; Brain; Clomipramine; Depression; Dopamine; Humans; Hydroxyindoleacetic Acid; Lithium; Model | 1976 |
Major depression: its recognition and treatment. Part 2. Second-generation and newer antidepressants.
Topics: Antidepressive Agents; Bupropion; Clomipramine; Depression; Female; Fluoxetine; Humans; Male; Maprot | 1992 |
Individualization of treatment with tricyclic compounds.
Topics: Animals; Antidepressive Agents; Chromatography, Gas; Clomipramine; Depression; Drug Interactions; El | 1974 |
58 trials available for clomipramine and Depression
| Article | Year |
|---|---|
Therapeutic alliance in short-term supportive and psychodynamic psychotherapies: a necessary but not sufficient condition for outcome?
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents, Tricyclic; Clomipramine; Depression; Femal | 2009 |
Chronic treatment with antidepressants decreases intraoperative core hypothermia.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricy | 2003 |
[Study on Modified Xiaoyao Decoction combining Clomipramine treating depression].
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depression; Drug Therapy, Combina | 2007 |
Fluvoxamine and clomipramine in depressed patients. A double-blind clinical study.
Topics: Adult; Aged; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Depression; Diazepam; Do | 1981 |
Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment.
Topics: Adult; Blood Platelets; Brompheniramine; Carbon Radioisotopes; Clomipramine; Depression; Female; Hum | 1983 |
Intravenous maprotiline in severe and resistant primary depression: a double-blind comparison with clomipramine.
Topics: Adolescent; Adult; Aged; Anthracenes; Clinical Trials as Topic; Clomipramine; Depression; Double-Bli | 1983 |
Tricyclic antidepressants in obsessive-compulsive disorder. Antiobsessional or antidepressant agents?
Topics: Adolescent; Adult; Aged; Anxiety; Clinical Trials as Topic; Clomipramine; Depression; Female; Humans | 1983 |
[Pain and depressive symptoms in general practice. A controlled study of Anafranil (clomipramine) versus placebo].
Topics: Adult; Clinical Trials as Topic; Clomipramine; Depression; Diagnosis, Differential; Double-Blind Met | 1984 |
Clomipramine and exposure for obsessive-compulsive rituals: i.
Topics: Adolescent; Adult; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Depression; Double-Blin | 1980 |
[Clinical trial of Tegretol and Anafranil/Sinequan in alcohol abstinence symptoms].
Topics: Alcoholism; Carbamazepine; Clinical Trials as Topic; Clomipramine; Depression; Double-Blind Method; | 1980 |
A beta adrenergic stimulant (salbutamol) versus clomipramine in depression: a controlled study.
Topics: Adolescent; Adult; Aged; Albuterol; Clinical Trials as Topic; Clomipramine; Depression; Female; Huma | 1980 |
A placebo-controlled comparative study of the combined effects of oxprenolol and clomipramine in depressed patients.
Topics: Adult; Aged; Clinical Trials as Topic; Clomipramine; Depression; Double-Blind Method; Drug Therapy, | 1980 |
Double-blind trial of amineptine and clomipramine in the treatment of depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Clomipramine; D | 1981 |
Doctor's versus patient's judgement in the assessment of mixed anxiety/depressive illness. Implications for measurement of therapeutic response.
Topics: Adult; Aged; Anxiety; Clinical Trials as Topic; Clomipramine; Depression; Drug Combinations; Female; | 1981 |
Mianserin and clomipramine in the treatment of depression.
Topics: Adult; Aged; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Double-Blind Method | 1982 |
Urinary amine metabolites in depression: a combined biochemical and general practice study: I. Clinical aspects.
Topics: Adolescent; Adult; Aged; Biogenic Amines; Clomipramine; Depression; Diet; Family Practice; Female; H | 1980 |
Andrological findings in young patients under long-term antidepressive therapy with clomipramine.
Topics: Adult; Androgens; Clomipramine; Depression; Erectile Dysfunction; Humans; Male; Middle Aged; Semen; | 1994 |
Buspirone augmentation of antidepressant therapy.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Buspirone; Clomipramine; Depression; Female | 1998 |
Clomipramine concentration as a predictor of delayed response: a naturalistic study.
Topics: Adult; Antidepressive Agents, Tricyclic; Chromatography, Gas; Clomipramine; Depression; Dose-Respons | 1999 |
Pharmacokinetics of a sustained-release dosage form of clomipramine.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Tricyclic; Clomipramine; Cross-Over Studies; Del | 2000 |
Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Blood Pressure; Brain; Brain Chemistry; Clomipramin | 2001 |
Long-term effects of tricyclic antidepressants on norepinephrine kinetics in humans.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Blood Pressure; Brain; Brain Chemistry; Clom | 2001 |
[Comparative study of three psychotropics for treatment of depressions].
Topics: Adult; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Doxepin; Female; Humans; | 1976 |
Letter: Potentiation of antidepressant action of clomipramine by tryptophan.
Topics: Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Drug Synergism; Drug Therapy, Co | 1975 |
Letter: Combined sleep deprivation and clomipramine in primary depression.
Topics: Adult; Clomipramine; Depression; Dibenzazepines; Humans; Middle Aged; Remission, Spontaneous; Sleep | 1976 |
A comparative trial of Anafranil, Pertofran and an Anafranil/Pertofran combination.
Topics: Adolescent; Adult; Clinical Trials as Topic; Clomipramine; Depression; Desipramine; Dibenzazepines; | 1977 |
[Clinical and experimental experiences with maprotiline, clomipramine, sydnocarb and mefexamide in mentally-ill patients and in healthy persons].
Topics: Adult; Anthracenes; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Female; Glyc | 1977 |
Controlled study comparing nomifensine and clomipramine in unipolar depression, using the probenecid technique.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Double-Blind Method; Fema | 1977 |
Some observations on patient compliance in an antidepressive trial.
Topics: Anthracenes; Chromatography, Gas; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines | 1977 |
Clinical responses in depressed patients in relation to plasma levels of tricyclic antidepressants and tyramine pressor response.
Topics: Adjustment Disorders; Adult; Aged; Anthracenes; Clinical Trials as Topic; Clomipramine; Depression; | 1977 |
Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
Topics: Adolescent; Adult; Aged; Anthracenes; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazep | 1977 |
Tyramine pressor responses and plasma levels during tricyclic antidepressant therapy.
Topics: Anthracenes; Blood Pressure; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Dou | 1977 |
Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Bethanidine; Blood Pressure; Cardiovascular | 1978 |
Tricyclic antidepressants in the treatment of depressions. A double-blind clinical comparison of clomipramine (Anafranil) and amitriptyline.
Topics: Adult; Aged; Ambulatory Care; Amitriptyline; Clinical Trials as Topic; Clomipramine; Depression; Dib | 1978 |
Single versus divided daily dosages of clomipramine. Plasma concentration and clinical effect.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepine | 1979 |
Clomipramine-induced mania in unipolar depression.
Topics: Adult; Age Factors; Aged; Amitriptyline; Bipolar Disorder; Brain Chemistry; Clomipramine; Depression | 1979 |
Plasma prolactin concentrations in normal subjects and depressive patients following oral clomipramine.
Topics: Administration, Oral; Adolescent; Adult; Aged; Clomipramine; Depression; Dibenzazepines; Female; Hum | 1977 |
[Comparative study of the pharmacological and clinical effects of clorimipramine and metaprimine (19560 R.P.)].
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depression; Dibenzazepines; Female; Humans; M | 1978 |
Psychomotor skills in depressed out-patients treated with L-tryptophan, doxepin, or chlorimipramine.
Topics: Adult; Attention; Clomipramine; Depression; Dibenzazepines; Doxepin; Female; Humans; Male; Middle Ag | 1978 |
Plasma concentrations of clomipramine and its N-desmethyl metabolite in depressive patients following treatment with various dosage regimes of clomipramine.
Topics: Adolescent; Adult; Clomipramine; Depression; Dibenzazepines; Drug Administration Schedule; Female; H | 1977 |
[The clomipramine-lithium combination: controlled trial].
Topics: Adjustment Disorders; Adult; Aged; Bipolar Disorder; Clinical Trials as Topic; Clomipramine; Depress | 1976 |
Tryptophan, 5-hydroxytryptophan and tricyclic antidepressants in the treatment of depression.
Topics: 5-Hydroxytryptophan; Catecholamines; Clinical Trials as Topic; Clomipramine; Depression; Depression, | 1976 |
Anafranil in obsessive compulsive neurosis.
Topics: Adult; Anxiety; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Female; Humans; | 1975 |
Potentiation of the antidepressant action of clomipramine by tryptophan.
Topics: Adolescent; Adult; Aged; Anxiety; Clomipramine; Depression; Dibenzazepines; Drug Synergism; Drug The | 1976 |
[Combined sleep deprivation/chlorimipramine therapy of endogenous depression (author's transl)].
Topics: Adult; Clomipramine; Depression; Dibenzazepines; Humans; Middle Aged; Sleep Deprivation; Time Factor | 1976 |
Changes in obsessive/compulsive patients as measured by the Leyton Inventory before and after treatment with clomipramine.
Topics: Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Humans; Obsessive-Compulsive Dis | 1975 |
Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--I. Report on an uncontrolled clinical trial.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Mid | 1976 |
Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--II. Report on a placebo-controlled clinical trial.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Mid | 1976 |
Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--III. Standard-controlled clinical trial.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Female; Humans; Imipramin | 1976 |
Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--IV. A summary report.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Mid | 1976 |
Tricyclic antidepressants and tryptophan in unipolar depression.
Topics: Clomipramine; Depression; Desipramine; Dibenzazepines; Drug Therapy, Combination; Female; Humans; Ma | 1975 |
Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Danish University Antidepressant Group.
Topics: Adult; Aged; Clomipramine; Cytochrome P-450 Enzyme System; Debrisoquin; Depression; Female; Humans; | 1992 |
Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
Topics: Adult; Analysis of Variance; Anxiety; Clomipramine; Clonazepam; Clonidine; Depression; Double-Blind | 1992 |
Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial.
Topics: Adult; Brain; Clomipramine; Depression; Double-Blind Method; Female; Humans; Irritable Mood; Persona | 1992 |
Double-blind study of the chronopharmacotherapy of depression.
Topics: Administration, Oral; Adolescent; Adult; Aged; Clomipramine; Depression; Double-Blind Method; Drug A | 1991 |
A double-blind group comparison of mianserin and clomipramine in the treatment of mildly depressed psychiatric out-patients.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; | 1985 |
Effect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramine.
Topics: Adult; Blood Pressure; Clomipramine; Depression; Double-Blind Method; Female; Heart Rate; Humans; Hy | 1989 |
Differential effect of chlorimipramine and nortriptyline on cerebrospinal fluid metabolites of serotonin and noradrenaline in depression.
Topics: Clomipramine; Depression; Dibenzazepines; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglyc | 1974 |
177 other studies available for clomipramine and Depression
| Article | Year |
|---|---|
Brain Metabolic Profile after Intranasal vs. Intraperitoneal Clomipramine Treatment in Rats with Ultrasound Model of Depression.
Topics: Administration, Intranasal; Animals; Antidepressive Agents; Behavior, Animal; Brain; Clomipramine; D | 2021 |
Chronic clomipramine treatment increases hippocampal volume in rats exposed to chronic unpredictable mild stress.
Topics: Animals; Antidepressive Agents; Clomipramine; Depression; Disease Models, Animal; Hippocampus; Human | 2022 |
Synergistic effects of
Topics: Animals; Clomipramine; Curcumin; Depression; Depressive Disorder; Disease Models, Animal; Glutamine; | 2022 |
Effect of Epigallocatechin-3-gallate on Stress-Induced Depression in a Mouse Model: Role of Interleukin-1β and Brain-Derived Neurotrophic Factor.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antioxidants; Brain-Derived Neurot | 2022 |
Alterations of learning and memory are accompanied by alterations in the expression of 5-HT receptors, glucocorticoid receptor and brain-derived neurotrophic factor in different brain regions of an animal model of depression generated by neonatally male t
Topics: Animals; Brain; Brain-Derived Neurotrophic Factor; Clomipramine; Depression; Disease Models, Animal; | 2023 |
Neonatal treatment with clomipramine modifies the expression of estrogen receptors in brain areas of male adult rats.
Topics: Amygdala; Animals; Animals, Newborn; Behavior, Animal; Brain; Clomipramine; Depression; Estradiol; E | 2019 |
Brain stimulation rewarding experience attenuates neonatal clomipramine-induced adulthood anxiety by reversal of pathological changes in the amygdala.
Topics: Amygdala; Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Anxiety; Biogenic Monoamines; | 2020 |
Differential effects of clomipramine on depression-like behaviors induced by the chronic social defeat paradigm in tree shrews.
Topics: Anhedonia; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Depression; Di | 2018 |
Involvement of the microglial NLRP3 inflammasome in the anti-inflammatory effect of the antidepressant clomipramine.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Clomipramine; Cytokines; Depression; Depre | 2019 |
Roman chamomile inhalation combined with clomipramine treatment improves treatment-resistant depression-like behavior in mice.
Topics: Animals; Behavior, Animal; Cell Proliferation; Chamaemelum; Clomipramine; Corticosterone; Cytokines; | 2019 |
Zinc improves clomipramine effects on depressive and locomotor behavior and reverses its oxidative stress in rats.
Topics: Animals; Antidepressive Agents; Clomipramine; Depression; Depressive Disorder; Disease Models, Anima | 2019 |
Clomipramine reverses hypoalgesia/hypoesthesia and improved depressive-like behaviors induced by inescapable shock in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Anxiety; Avoidance Learning; Clomipramine; Depression; El | 2013 |
Phospholipase D-mTOR signaling is compromised in a rat model of depression.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Brain; Choline; Clomipramine; Depressio | 2013 |
Electrocardiographic changes upon tricyclic antidepressant administration mimicking Brugada syndrome.
Topics: Antidepressive Agents, Tricyclic; Brugada Syndrome; Bundle-Branch Block; Clomipramine; Depression; E | 2013 |
Effects of chronic antidepressant treatments in a putative genetic model of vulnerability (Roman low-avoidance rats) and resistance (Roman high-avoidance rats) to stress-induced depression.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Avoidance Learning; Behavior, Anim | 2014 |
Altered expression of 5-HT1A receptors in adult rats induced by neonatal treatment with clomipramine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aging; Animals; Animals, Newborn; Body Temperature; Clomipra | 2014 |
Chronic clomipramine treatment reverses core symptom of depression in subordinate tree shrews.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Depression; Humans; Hydro | 2013 |
Antidepressant-like effect of simvastatin in diabetic rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Clomipramine; Corticosterone; Depression; Diabetes | 2015 |
The first observation of seasonal affective disorder symptoms in Rhesus macaque.
Topics: Animals; Antidepressive Agents, Tricyclic; Body Weight; Clomipramine; Depression; Disease Models, An | 2015 |
Pharmacokinetics of clomipramine during pregnancy.
Topics: Adult; Antidepressive Agents, Tricyclic; Chromatography, Liquid; Clomipramine; Depression; Female; H | 2015 |
A neonatal prolonged QT syndrome due to maternal use of oral tricyclic antidepressants.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Tricyclic; Clomipramine; Depression; Female; Hum | 2016 |
Proteomic investigation of the prefrontal cortex in the rat clomipramine model of depression.
Topics: Animals; Animals, Newborn; Clomipramine; Depression; Female; Intramolecular Oxidoreductases; Macroph | 2017 |
Antidepressant-like effect of ethanol extract from Paeonia lactiflora in mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Blepharoptosis; Clomipramine; Depression; Dise | 2008 |
QEEG changes during switch from depression to hypomania/mania: a case report.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Brain; Clomipramine; Depression; Electroencephal | 2008 |
Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats.
Topics: Amino Acids; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Bridged Bicyclo Compounds, | 2008 |
Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine.
Topics: Animals; Animals, Newborn; Brain Chemistry; Clomipramine; Depression; Enzyme-Linked Immunosorbent As | 2008 |
Sex-related differential response to clomipramine treatment in a rat model of depression.
Topics: Animals; Antidepressive Agents, Tricyclic; Clomipramine; Depression; Disease Models, Animal; Female; | 2009 |
Air swallowing as a tic.
Topics: Aerophagy; Antidepressive Agents, Tricyclic; Clomipramine; Depression; Diagnosis, Differential; Gast | 2008 |
Immobility in the tail suspension test predicts quinine but not saccharin intake in mice.
Topics: Animals; Antidepressive Agents, Tricyclic; Choice Behavior; Clomipramine; Depression; Drinking Behav | 2009 |
Clomipramine treatment reversed the glial pathology in a chronic unpredictable stress-induced rat model of depression.
Topics: Animals; Clomipramine; Depression; Disease Models, Animal; Exploratory Behavior; Freezing Reaction, | 2009 |
Circadian activity of corticosterone in an animal model of depression: response to muscarinic cholinergic stimulation.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Behavior, Animal; Cholinergic A | 2010 |
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes.
Topics: Adrenergic beta-3 Receptor Agonists; Animals; Antidepressive Agents; Antidepressive Agents, Tricycli | 2010 |
Effects of antidepressants on the performance in the forced swim test of two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Clomipramine; Depression; Desi | 2010 |
Chronic escitalopram treatment restores spatial learning, monoamine levels, and hippocampal long-term potentiation in an animal model of depression.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents, Second | 2011 |
5-HT(1A), 5-HT(2A), and 5-HT(2C) receptor mRNA modulation by antidepressant treatment in the chronic mild stress model of depression: sex differences exposed.
Topics: Animals; Antidepressive Agents, Tricyclic; Brain; Clomipramine; Depression; Disease Models, Animal; | 2012 |
Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression.
Topics: Animals; Antidepressive Agents; Clomipramine; Depression; Glial Cell Line-Derived Neurotrophic Facto | 2012 |
Inter-tissue networks between the basal forebrain, hippocampus, and prefrontal cortex in a model for depression caused by disturbed sleep.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Clomipramine; Depression; Disease Model | 2012 |
Administration of clomipramine to neonatal mice alters stress response behavior and serotonergic gene expressions in adult mice.
Topics: Animals; Animals, Newborn; Antidepressive Agents; Behavior, Animal; Clomipramine; Depression; Female | 2013 |
Clomipramine treatment in neonatal rats alters the brain acetylcholinesterase activity in adulthood.
Topics: Acetylcholinesterase; Aging; Animals; Animals, Newborn; Brain; Clomipramine; Depression; Enzyme Acti | 2002 |
Differential neurochemical properties of central serotonergic transmission in Roman high- and low-avoidance rats.
Topics: Animals; Anxiety; Autoradiography; Avoidance Learning; Behavior, Animal; Binding, Competitive; Brain | 2003 |
Corticosterone and testosterone levels after chronic stress in an animal model of depression.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Behavior, Animal; | 2003 |
Impairments of ERK signal transduction in the brain in a rat model of depression induced by neonatal exposure of clomipramine.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Blotting, Western; Brain; Clomipramine; | 2003 |
Weekly treatments with a burst-firing magnetic field alters behavior in the elevated plus maze after two sessions.
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Conditioning, Psychologic | 2004 |
Examining novel concepts of the pathophysiology of depression in the chronic psychosocial stress paradigm in tree shrews.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cell Differentiation; Clomipramine | 2004 |
Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test).
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Corticosterone; Depressio | 2005 |
[Case report: taeniasis, is it a cause of psychiatric and neural symptoms?].
Topics: Adult; Animals; Anticestodal Agents; Antidepressive Agents, Tricyclic; Cathartics; Clomipramine; Con | 2006 |
Electroacupuncture combined with clomipramine enhances antidepressant effect in rodents.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Dep | 2007 |
Sucrose preference is restored by electro-acupuncture combined with chlorimipramine in the depression-model rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Clomipramine; Combined Modality Therapy; Depressio | 2006 |
Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Antagon | 2007 |
Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Second-Generation; | 2008 |
Antidepressant drugs and the hypothalamic-pituitary-thyroid axis.
Topics: Clomipramine; Depression; Female; Hormones; Humans; Prognosis; Recurrence; Thyrotropin; Thyrotropin- | 1980 |
Dexamethasone suppression test identifies subtypes of depression which respond to different antidepressants.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Clomipramine; Depression; Depression, Chemic | 1980 |
Biological aspects of clomiprimine III. Preface.
Topics: Clomipramine; Congresses as Topic; Depression; Drug Evaluation; Humans | 1980 |
Beta-adrenergic stimulation and antidepressant activity.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Antidepressive Agents; Behavior, Animal; Clomipramine; | 1981 |
Amine metabolism, thyroid function and response to clomipramine and maprotiline medication in depression.
Topics: Adolescent; Adult; Aged; Anthracenes; Clomipramine; Depression; Female; Humans; Hydroxyindoleacetic | 1980 |
Cortisol in the CSF of depressed and suicidal patients.
Topics: Adjustment Disorders; Clomipramine; Depression; Female; Homovanillic Acid; Humans; Hydrocortisone; H | 1980 |
Urinary amine metabolites in depression: a combined biochemical and general practice study: II. Biochemical aspects.
Topics: Adolescent; Adult; Aged; Biogenic Amines; Clomipramine; Depression; Family Practice; Female; Humans; | 1980 |
Studies of CSF 5-HIAA in depression and suicidal behaviour.
Topics: Blood Platelets; Clomipramine; Depression; Gas Chromatography-Mass Spectrometry; Humans; Hydrocortis | 1981 |
Relevance of tryptophan and tyrosine availability in endogenous and 'non-endogenous' depressives treated with imipramine or clomipramine.
Topics: Biological Availability; Clomipramine; Depression; Depressive Disorder; Humans; Imipramine; Time Fac | 1981 |
[N-dealkylation of chlorimipramine and chlorpromazine in patients undergoing chronic treatment with both drugs: preliminary results].
Topics: Chlorpromazine; Clomipramine; Depression; Dissociative Disorders; Humans; Imipramine | 1984 |
Variation in plasma concentrations of clomipramine and desmethylclomipramine during clomipramine therapy.
Topics: Adolescent; Adult; Aged; Circadian Rhythm; Clomipramine; Depression; Female; Humans; Male; Middle Ag | 1980 |
Clomipramine and oral contraceptives: an interaction study--clinical findings.
Topics: Adolescent; Adult; Clomipramine; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Depression; D | 1980 |
Clomipramine and age: an interaction study.
Topics: Adolescent; Adult; Aged; Aging; Clomipramine; Depression; Female; Humans; Male; Psychiatric Status R | 1980 |
Clomipramine and smoking: an interaction study--clinical findings.
Topics: Adult; Aged; Clomipramine; Depression; Female; Humans; Male; Middle Aged; Psychiatric Status Rating | 1980 |
Relating plasma levels of clomipramine and clinical response.
Topics: Adult; Aged; Aging; Clomipramine; Contraceptives, Oral, Hormonal; Depression; Female; Humans; Male; | 1980 |
Effects of age, cigarette smoking and the oral contraceptive on the pharmacokinetics of clomipramine and its desmethyl metabolite during chronic dosing.
Topics: Adolescent; Adult; Aged; Aging; Clomipramine; Contraceptives, Oral; Contraceptives, Oral, Hormonal; | 1980 |
Preliminary observations of the significance of monitoring tricyclic antidepressant plasma levels in the pediatric patient.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Child; Child, Preschool; Clomipramine; Depressi | 1980 |
[Treatment of orthostatic hypotension induced by tricyclic antidepressants with yohimbine (author's transl)].
Topics: Blood Pressure; Clomipramine; Depression; Double-Blind Method; Humans; Hypotension, Orthostatic; Yoh | 1980 |
A sensitive and specific method for the determination of chlorimipramine and desmethylchlorimipramine in plasma using selected ion monitoring with chemical ionization.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Depression; Gas Chromatography-Mass Spectrometry; Hu | 1980 |
[Latent or masked depression and depressive equivalents. Presentation of 2 clinical cases].
Topics: Adult; Antidepressive Agents; Clomipramine; Depression; Female; Humans; Male; Middle Aged; Psychophy | 1980 |
Intravenous chlorimipramine and refractory depression.
Topics: Adult; Bipolar Disorder; Clomipramine; Depression; Hemodynamics; Humans; Infusions, Parenteral; Male | 1980 |
Single oral dose pharmacokinetics of clomipramine in depressed patients.
Topics: Administration, Oral; Adult; Aged; Clomipramine; Depression; Drug Administration Schedule; Female; H | 1980 |
Unusual plasma level oscillations of clomipramine in man: a pharmacokinetic and pharmacodynamic dilemma.
Topics: Administration, Oral; Adult; Clomipramine; Depression; Humans; Infusions, Parenteral; Kinetics; Male | 1980 |
Plasma levels and clinical improvement--a comparative study of clomipramine and amitriptyline in depression.
Topics: Amitriptyline; Clomipramine; Depression; Female; Humans; Male; Nortriptyline | 1980 |
Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients.
Topics: Adult; Aged; Clomipramine; Depression; Female; Humans; Male; Middle Aged; Time Factors | 1980 |
Ethnic differences in drug response.
Topics: Asia; Clomipramine; Depression; Environment; Ethnicity; Humans; Kinetics; United Kingdom; United Sta | 1980 |
Influence of age, cigarette smoking and the oral contraceptive on plasma concentrations of clomipramine.
Topics: Adolescent; Adult; Aged; Aging; Clomipramine; Contraceptives, Oral; Depression; Female; Humans; Male | 1980 |
[Infusion treatment of depression].
Topics: Administration, Oral; Ambulatory Care; Antidepressive Agents, Tricyclic; Clomipramine; Depression; D | 1980 |
Pharmacologic management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depression; Dopamine; Fluox | 1994 |
DMBA-induced mammary tumor growth in rats exhibiting increased or decreased ability to cope with stress due to early postnatal handling or antidepressant treatment.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adaptation, Psychological; Animals; Animals, Newborn; Arousal; Clo | 1993 |
Effects of tryptophan and serotonin uptake inhibitors on behavior in male transgenic transforming growth factor alpha mice.
Topics: Aggression; Animals; Behavior, Animal; Clomipramine; Depression; Male; Mice; Mice, Transgenic; Selec | 1993 |
Desensitization of the D1 dopamine receptors in rats reproduces a model of escape deficit reverted by imipramine, fluoxetine and clomipramine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Clomipramine; Depression; Disea | 1995 |
Amaurosis fugax on standing and angle-closure glaucoma with clomipramine.
Topics: Antidepressive Agents, Tricyclic; Blindness; Clomipramine; Depression; Female; Glaucoma, Angle-Closu | 1996 |
Effects of chronic treatment with zimelidine and REM sleep deprivation on the regulation of raphe neuronal activity in a rat model of depression.
Topics: Animals; Citalopram; Clomipramine; Depression; Dose-Response Relationship, Drug; Electrophysiology; | 1996 |
Successful treatment of serotonin syndrome with chlorpromazine.
Topics: Central Nervous System Diseases; Chlorpromazine; Clomipramine; Depression; Drug Interactions; Humans | 1996 |
Decreased dorsal raphe nucleus neuronal activity in adult chloral hydrate anesthetized rats following neonatal clomipramine treatment: implications for endogenous depression.
Topics: Anesthesia; Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Chloral Hydrate; Clomiprami | 1997 |
Pharmacological features of masculine sexual behavior in an animal model of depression.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Animals; Animals, Newborn; Clo | 1998 |
Depressive symptomatology during clozapine treatment: two case reports.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Age | 1998 |
Neonatal clomipramine treatment, alcohol intake and circadian rhythms in rats.
Topics: Alcohol Drinking; Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Circadian Rhythm; Clo | 1998 |
Hyperactivity of hypothalamic pituitary axis in neonatal clomipramine model of depression.
Topics: Animals; Animals, Newborn; Clomipramine; Depression; Depression, Chemical; Dexamethasone; Disease Mo | 1998 |
Alterations in the levels of monoamines in discrete brain regions of clomipramine-induced animal model of endogenous depression.
Topics: Aggression; Animals; Biogenic Monoamines; Brain; Brain Stem; Clomipramine; Depression; Disease Model | 1999 |
Serotonin syndrome as a result of clomipramine monotherapy.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Depression; Female; Humans; Middle Aged; Selective S | 1999 |
Abnormal monoamine metabolism in cerebrospinal fluid in a case of serotonin syndrome.
Topics: Adult; Amoxapine; Biogenic Monoamines; Clomipramine; Depression; Humans; Male; Selective Serotonin R | 2000 |
Long photoperiod regimen may produce antidepressant actions in the male rat.
Topics: Animals; Antidepressive Agents, Tricyclic; Clomipramine; Conditioning, Operant; Depression; Desipram | 2000 |
Effects of REM sleep deprivation on cholinergic receptor sensitivity and passive avoidance behavior in clomipramine model of depression.
Topics: Animals; Animals, Newborn; Avoidance Learning; Clomipramine; Depression; Male; Motor Activity; Musca | 2000 |
The differential effects of calcium channel blockers in the behavioural despair test in mice.
Topics: Animals; Antidepressive Agents; Calcium Channel Blockers; Clomipramine; Clonidine; Cyproheptadine; D | 2000 |
Effects of acute or chronic administration of substituted benzamides in experimental models of depression in rats.
Topics: Animals; Antidepressive Agents; Benzamides; Clomipramine; Depression; Disease Models, Animal; Dose-R | 2000 |
Population pharmacokinetics of clomipramine, desmethylclomipramine, and hydroxylated metabolites in patients with depression receiving chronic treatment: model evaluation.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Clomipramine; Computer Simulation; Depression; Drug A | 2000 |
Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments?
Topics: Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Depression; Disease Model | 2001 |
Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and antidepressant treatment.
Topics: Adult; Affect; Antidepressive Agents; Circadian Rhythm; Clomipramine; Depression; Female; Humans; Ma | 2001 |
The critical window of brain development from susceptive to insusceptive. Effects of clomipramine neonatal treatment on sexual behavior.
Topics: Animals; Animals, Newborn; Brain; Clomipramine; Critical Period, Psychological; Depression; Disease | 2001 |
Availability of learned helplessness test as a model of depression compared to a forced swimming test in rats.
Topics: Amoxapine; Animals; Antidepressive Agents; Behavior, Animal; Clomipramine; Depression; Disease Model | 2001 |
Altered dendritic spine density in animal models of depression and in response to antidepressant treatment.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Clomipramine; Dendrites; Denervation; D | 2001 |
Clomipramine suppresses postnatal REM sleep without increasing wakefulness: implications for the production of depressive behaviors.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Behavior, Animal; Clomipramine; Depress | 2002 |
Mimosa pudica may possess antidepressant actions in the rat.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Clomipramine; Depression; Desipramine; Fabaceae; M | 1999 |
[The pharmacotherapy of masked depression].
Topics: Adrenergic beta-Agonists; Anthracenes; Clomipramine; Depression; Dibenzazepines; Drug Therapy, Combi | 1975 |
Treatment of depression with tricyclic drugs--pharmacokinetic and pharmacodynamic aspects.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Depression; Homovanillic Acid; Humans; Hydroxyindole | 1976 |
Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
Topics: Biogenic Amines; Clomipramine; Depression; Depression, Chemical; Dibenzazepines; Homovanillic Acid; | 1977 |
[Suppression of the antihypertensive effect of clonidine by the simultaneous intake of a tricyclic antidepressive agent. Practical problem in the treatment of a depressed hypertensive patient].
Topics: Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Clomi | 1977 |
Sleep deprivation and clomipramine in endogenous depression.
Topics: Clomipramine; Depression; Dibenzazepines; Humans; Maprotiline; Sleep Deprivation | 1976 |
[Clinical and biochemical contributions on the action of maprotiline and clomipramine in depressive states (preliminary observation)].
Topics: Adult; Bipolar Disorder; Clomipramine; Depression; Female; Humans; Hydroxyindoleacetic Acid; Male; M | 1979 |
[Clinical and biochemical contributions on the effect of maprotiline and clomipramine in depressive states (preliminary observation)].
Topics: Adjustment Disorders; Adult; Anthracenes; Blood Platelets; Clomipramine; Depression; Female; Humans; | 1979 |
Urinary adenosine 3',5'-cyclic monophosphate: effects of electroconvulsive therapy.
Topics: Clomipramine; Cyclic AMP; Depression; Electroconvulsive Therapy; Humans; Psychiatric Status Rating S | 1976 |
Mass fragmentographic analysis of clomipramine and its mono-demethylated metabolite in human plasma.
Topics: Adult; Clomipramine; Dealkylation; Depression; Dibenzazepines; Female; Gas Chromatography-Mass Spect | 1977 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
A new depression scale designed to be sensitive to change.
Topics: Adolescent; Adult; Aged; Amitriptyline; Clomipramine; Depression; England; Female; Humans; Male; Map | 1979 |
Clinical response and tricyclic plasma levels during treatment with clomipramine.
Topics: Administration, Oral; Adult; Aged; Clomipramine; Depression; Dibenzazepines; Drug Administration Sch | 1979 |
Techniques for plasma protein binding of demethylchlorimipramine.
Topics: Blood Proteins; Clomipramine; Compulsive Personality Disorder; Depression; Dialysis; Dibenzazepines; | 1979 |
Response to sleep deprivation as a predictor of therapeutic results with antidepressant drugs.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Depression; Female; Humans; Imipramine; Male; Maprot | 1979 |
3-Methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations.
Topics: Adult; Aged; Amitriptyline; Bipolar Disorder; Clomipramine; Depression; Female; Glycols; Humans; Mal | 1979 |
Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression.
Topics: Adult; Age Factors; Aged; Animals; Biological Transport; Brain; Clomipramine; Depression; Female; Hu | 1979 |
Effects of somatic treatments on mood in endogenous depression.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Clomipramine; Depression; Desipramine | 1979 |
[Treatment of therapy resistant depressions with high dose clomipramine].
Topics: Adult; Aged; Clomipramine; Depression; Drug Resistance; Female; Humans; Male; Middle Aged | 1979 |
Intraindividual similarity in the metabolism of amitriptyline and chlorimipramine in depressed patients.
Topics: Amitriptyline; Clomipramine; Dealkylation; Depression; Humans; Kinetics | 1979 |
Antidepressive treatment and mood swing patterns in endogenous depression.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Bipolar Disorder; Clomipra | 1979 |
Clomipramine: plasma levels and clinical effects.
Topics: Adult; Aged; Clomipramine; Dealkylation; Depression; Female; Humans; Male; Middle Aged; Placebos; Ps | 1979 |
Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.
Topics: Antidepressive Agents, Tricyclic; Biotransformation; Clomipramine; Depression; Desipramine; Dibenzoc | 1979 |
Clomipramine (Anafranil) in depressive patients with obsessive neurosis.
Topics: Adult; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Obsessive-Compulsive Disorder | 1977 |
Treatment of obsessive-compulsive neurosis with clomipramine (Anafranil).
Topics: Adult; Aged; Anxiety; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Middle Aged; O | 1977 |
Clinical experience in the treatment of obsessional states (2).
Topics: Clomipramine; Depression; Dibenzazepines; Humans; Obsessive-Compulsive Disorder; Phobic Disorders | 1977 |
Clomipramine plasma level and clinical response.
Topics: Administration, Oral; Adult; Aged; Body Weight; Clomipramine; Depression; Dibenzazepines; Female; Hu | 1977 |
Clomipramine and maprotiline on human platelet uptake of 5-hydroxytryptamine and dopamine in vitro: what relevance to their antidepressive and other central actions?
Topics: Anthracenes; Blood Platelets; Clomipramine; Depression; Dibenzazepines; Dopamine; Humans; In Vitro T | 1977 |
The effect of depression and its treatment on serum thyroxine.
Topics: Clomipramine; Depression; Dibenzazepines; Humans; Maprotiline; Thyroxine | 1977 |
Plasma level studies of clomipramine and desmethylclomipramine following intravenous infusions of clomipramine in depressive patients.
Topics: Adolescent; Adult; Clomipramine; Depression; Dibenzazepines; Female; Humans; Infusions, Parenteral; | 1977 |
[Management of treatment-resistant depression (author's transl)].
Topics: Administration, Oral; Antidepressive Agents; Autogenic Training; Bipolar Disorder; Clomipramine; Dep | 1978 |
[Clomipramine (monochlorimipramine) produced in the GDR].
Topics: Clomipramine; Depression; Dibenzazepines; Germany, East; Humans | 1978 |
The effects of clomipramine on depression in Barbadian patients.
Topics: Adult; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Pilot Projects | 1978 |
Psychiatric problems in intensive care. Five patients with acute confusional states and depression.
Topics: Adult; Aged; Clomipramine; Cognition Disorders; Confusion; Consciousness Disorders; Critical Care; D | 1976 |
The use of clomipramine in phobic patients. Preliminary research report.
Topics: Adolescent; Adult; Anxiety; Clomipramine; Depression; Dibenzazepines; Drug Evaluation; Drug Toleranc | 1975 |
Depressive subtypes, blood pressure changes and response to treatment.
Topics: Adult; Age Factors; Aged; Anxiety Disorders; Bipolar Disorder; Blood Pressure; Clomipramine; Depress | 1977 |
Relationships between clinical response, plasma levels and side-effects of clomipramine (Anafranil) in general practitioner trials.
Topics: Adolescent; Adult; Aged; Clomipramine; Depression; Dibenzazepines; Dose-Response Relationship, Drug; | 1977 |
A clinical trial of a 50 mg formulation of clomipramine (Anafranil) with steady-state plasma level measurements.
Topics: Adult; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Middle Aged; Pilot Projects; | 1977 |
Comparisons of various clomipramine (Anafranil) dosage regimes.
Topics: Adult; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Middle Aged; Psychiatric Stat | 1977 |
Sexual side-effects of clomipramine (Anafranil).
Topics: Adult; Clomipramine; Coitus; Depression; Dibenzazepines; Female; Humans; Male; Orgasm; Sexual Behavi | 1977 |
Plasma level studies with clomipramine (anafranil)
Topics: Adult; Aged; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Middle Aged | 1977 |
[Metoclopramide (Cerucal) side-effects in the form of extrapyramidal disorders in combination with an other antidepressive agent].
Topics: Adult; Basal Ganglia Diseases; Clomipramine; Depression; Drug Combinations; Female; Gastrointestinal | 1977 |
[Tricyclic antidepressive agents in refractory depressions].
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Depression; Dose-Response Relationship, Drug; | 1977 |
Investigation of the orthostatic reaction after intravenous administration of imipramine, chlorimipramine, and inimpramine-N-oxide.
Topics: Adult; Aged; Blood Pressure; Clomipramine; Depression; Dibenzazepines; Dose-Response Relationship, D | 1976 |
Platelet uptake of 5-hydroxytryptamine and dopamine in depression.
Topics: Blood Platelets; Clomipramine; Depression; Dopamine; Humans; Protriptyline; Serotonin | 1976 |
Tricyclic antidepressants, tryptophan and affective disorder.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Depression; Desipramine; Humans; Serotonin; Tryptoph | 1976 |
The effect of clomipramine on prolactin levels--pilot studies.
Topics: Adult; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Prolactin | 1976 |
Effect of flupenthixol on depression with special reference to combination use with tricyclic antidepressants. An uncontrolled pilot study with 45 patients.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Child; Clomipramine; Depre | 1976 |
Agranulocytosis and systemic candidiasis following clomipramine therapy.
Topics: Adult; Agranulocytosis; Candidiasis; Clomipramine; Depression; Dibenzazepines; Female; Flucytosine; | 1976 |
[Psychotropic drugs and glaucoma (author's transl)].
Topics: Adult; Aged; Clomipramine; Depression; Desipramine; Dibenzocycloheptenes; Female; Fluphenazine; Glau | 1976 |
[Description of a simple graphic model permitting the comparison of the course of depressive states].
Topics: Adjustment Disorders; Adult; Antidepressive Agents; Anxiety; Clomipramine; Depression; Doxepin; Fema | 1976 |
Central monoamine deficiency in depressions: causative of secondary phenomenon?
Topics: 5-Hydroxytryptophan; Clomipramine; Depression; Dopamine; Homovanillic Acid; Humans; Serotonin | 1975 |
Psychological medicine. Management of depression.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Clomipramine; Depression; Drug Interactions; Electroc | 1975 |
Depressive reactions in the course of clomipramine therapy used in the treatment of obsessional conditions.
Topics: Adult; Aged; Amitriptyline; Clomipramine; Depression; Dibenzazepines; Female; Flupenthixol; Humans; | 1975 |
A pilot study of anafranil in the treatment of phobic states.
Topics: Administration, Oral; Adult; Alcoholism; Blood Pressure; Clomipramine; Depression; Dibenzazepines; D | 1975 |
A preliminary report on the use of clomipramine in general practice.
Topics: Administration, Oral; Adult; Aged; Alcoholism; Clomipramine; Depression; Dibenzazepines; Family Prac | 1975 |
[Mania complicating treatment of unipolar vital depression].
Topics: Adult; Aged; Amitriptyline; Bipolar Disorder; Clomipramine; Depression; Dibenzazepines; Female; Huma | 1975 |
Proceedings: Clomipramine in the treatment of depressions.
Topics: Adult; Clomipramine; Depression; Dibenzazepines; Female; Humans; Male; Middle Aged | 1975 |
Intravenous chlorimipramine and depressive subtypes.
Topics: Adult; Aged; Bipolar Disorder; Blood Pressure; Clomipramine; Depression; Dibenzazepines; Drug Evalua | 1976 |
Neuroendocrine responses to L-tryptophan as an index of brain serotonin function: effect of weight loss.
Topics: Adult; Biological Transport, Active; Brain Chemistry; Clomipramine; Depression; Diet, Reducing; Fema | 1991 |
Trazodone treatment in clomipramine-resistant obsessive-compulsive disorder.
Topics: Adult; Analysis of Variance; Clinical Trials as Topic; Clomipramine; Depression; Drug Resistance; Fe | 1990 |
Abnormal neuroendocrine responsivity to clomipramine in depression.
Topics: Adult; Clomipramine; Depression; Female; Humans; Male; Neurosecretory Systems; Prolactin; Thyroid Fu | 1990 |
Absence of placebo response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Anxiety; Clomipramine; Depression; Double-Blind Method; Fear; Female; Human | 1990 |
Determination of fluoxetine and norfluoxetine by high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Clomipramine; Depression; Fluoxetine; Humans | 1990 |
Delusional depression responding to clomipramine in Binswanger's disease.
Topics: Clomipramine; Delusions; Dementia; Depression; Female; Humans; Middle Aged | 1990 |
[Determination of 3-methoxy-4-hydroxyphenyethylene-glycol and its urinary conjugates. Value in the diagnosis and therapeutic follow-up of depression].
Topics: Clomipramine; Depression; Drug Therapy, Combination; Follow-Up Studies; Glycols; Humans; Hydroxyindo | 1988 |
Hyponatraemia and clomipramine therapy.
Topics: Clomipramine; Depression; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged | 1989 |
Importance of oxidative polymorphism and levomepromazine treatment on the steady-state blood concentrations of clomipramine and its major metabolites.
Topics: Adult; Aged; Aged, 80 and over; Anti-Anxiety Agents; Benzodiazepines; Clomipramine; Debrisoquin; Dep | 1986 |
Animal depression model by neonatal clomipramine: reduction of shock induced aggression.
Topics: Age Factors; Aggression; Animals; Animals, Newborn; Clomipramine; Depression; Disease Models, Animal | 1988 |
Rothia dentocariosa septicaemia in a patient with chronic lymphocytic leukaemia and toxic granulocytopenia.
Topics: Actinomycetaceae; Actinomycetales Infections; Aged; Agranulocytosis; Clomipramine; Clopenthixol; Dep | 1987 |
Myoclonic movements as a side-effect of treatment with therapeutic doses of clomipramine.
Topics: Adult; Aged; Clomipramine; Depression; Female; Humans; Male; Middle Aged; Myoclonus | 1987 |
Response to sequential administration of clomipramine and lithium carbonate in treatment-resistant depression.
Topics: Aged; Clomipramine; Depression; Drug Synergism; Drug Therapy, Combination; Humans; Lithium; Lithium | 1985 |
[Preliminary results of a controlled trial with sulpiride versus chlorimipramine in chronic schizophrenic patients with marked ideo-emotional poverty (author's transl)].
Topics: Affect; Anxiety; Chronic Disease; Clomipramine; Depression; Dibenzazepines; Humans; Mental Processes | 1974 |
[Problems of differentiated thymoleptic therapy in phasic depressions].
Topics: Adolescent; Adult; Amitriptyline; Anthracenes; Antidepressive Agents; Azocines; Benzoates; Benzofura | 1974 |